.png)
COVID-19 Evidence Reviews
as of 2/26/21
= living review
= meets mimimum quality standards | A review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
 latest update date
 |
select |
|
|---|---|---|
|
2/26/21
|
Bezerra P, de Siqueira Barros Nogueira FG, dos Santos AC, et al. | medRxiv
Aim: To evaluate the repercussion of such disease over maternal fetal and neonatal mortality, need for intensive care, way of delivery, premature delivery, birth weight, Apgar score, presence of intrauterine growth restriction (IGR), and presence of amniotic fluid change.
|
|
|
2/25/21
|
Fomenko A, Weibel S, Moezi H, et al | PROSPERO
|
|
|
2/25/21
|
Xia L, Ramon J, Sha J, et al | PROSPERO
|
|
|
2/25/21
|
Arieta J, Salcedo Alcaychahua AB, Santos GMP, | PROSPERO
|
|
|
2/25/21
|
Calzetta L, Rogliani P | PROSPERO
|
|
|
2/25/21
|
Greenfield S, Damery S, Cartledge S, et al | PROSPERO
|
|
|
2/25/21
|
Blaabjerg J, Behrmann J, Josefine Jordansen, et al | PROSPERO
|
|
|
2/25/21
|
Nna E, Alao M, Anyachukwu C, et al | Research Square
|
|
|
2/25/21
|
Wei GX, Hao W, Qiuxia S, et al | PROSPERO
|
|
|
2/25/21
|
Kamarullah W, Stephanie K, Sabrina AP, et al | PROSPERO
|
|
|
2/25/21
|
David A, Park C | PROSPERO
|
|
|
2/25/21
|
Conde-Agudelo A, Romero R | PROSPERO
|
|
|
2/25/21
|
Yun L, Chen B, Hong Z, et al | PROSPERO
|
|
|
2/25/21
|
Cuevas-Gonzalez JC, Cuevas-Gonzalez MV | PROSPERO
|
|
|
2/25/21
|
Wright T, Keval H, Keys C, et al | PROSPERO
|
|
|
2/25/21
|
Sahebi A, Golitaleb M | PROSPERO
|
|
|
2/25/21
|
Sikhosana N, Fernandez R, Lord H | PROSPERO
|
|
|
2/24/21
|
Ost K, Duquesne L, Duguay C, et al. | medRxiv
Aim: To identify if and how equity has been considered in large-scale testing initiatives.
|
|
|
2/24/21
|
Vernooij RWM, Pieters T, van Balkom BWM, et al | PROSPERO
|
|
|
2/24/21
|
Viswanatha GL, Male C, Shylaja H | medRxiv
Aim: To evaluate the therapeutic benefits and safety of tocilizumab (TCZ) in treating severe coronavirus disease 2019 (COVID-19) and associated health complications.
|
|
|
2/24/21
|
Fangfang M, Hewei Z, Mingwei Y, et al | PROSPERO
|
|
|
2/23/21
|
O'Mahoney L, Ekezie W, Pareek M, et al | PROSPERO
|
|
|
2/23/21
|
Xiang HR, Cheng X, Li Y, et al | PROSPERO
|
|
|
2/23/21
|
Kamal A, Ekezie W, Farooqi A, et al | PROSPERO
|
|
|
2/23/21
|
Hao W, Xianwei G, Wangying S, et al | PROSPERO
|
|
|
2/23/21
|
Alasfour M, AlMojel M | PROSPERO
|
|
|
2/23/21
|
Ju J, Zhang Y, Wang H, et al | PROSPERO
|
|
|
2/23/21
|
Liang Q, Guo X, Su W, Li N, et al | PROSPERO
|
|
|
2/23/21
|
Long Q, Li J, Zheng Y, et al | PROSPERO
|
|
|
2/23/21
|
Rodriguez JG, Guirao E, Benavente A, et al | PROSPERO
|
|
|
2/23/21
|
Richter D, Riedel-Heller SG, Zuercher SJ | medRxiv
Aim: To review the evidence on the course of mental health problems during and after the first lockdown phase of the COVID-19 pandemic. RECENTLY UPDATED
|
|
|
2/23/21
|
Lin Y, Sun T, Yang X, et al | PROSPERO
|
|
|
2/23/21
|
Sahebi A, Golitaleb M | PROSPERO
|
|
|
2/23/21
|
Sutheno A, Pranajaya SB, Sucitra PB | PROSPERO
|
|
|
2/23/21
|
Starke KR, Treskova M, Petereit-Haack G, et al | PROSPERO
|
|
|
2/23/21
|
Mhish O, Tleyjeh IM, Kashour Z, et al | PROSPERO
|
|
|
2/22/21
|
Rycroft C, King-Okoye, Underwood T | PROSPERO
|
|
|
2/22/21
|
Kilian C, Manthey J, Rehm J, et al | PROSPERO
|
|
|
2/22/21
|
Officer A, Pautex S, Broers B | PROSPERO
|
|
|
2/22/21
|
Zawai AT, Naser AY, Alwafi H, et al. | medRxiv
Aim: To evaluate the inflammatory cytokines profile associated with severe human coronavirus diseases, including three stains: MERS-CoV, SARS-CoV SARS-CoV-2, in severe patients. RECENTLY UPDATED
|
|
|
2/22/21
|
Kuikel BS, Dangaura NR, Paneru B | PROSPERO
|
|
|
2/22/21
|
Isaura ER, Paramastri R | PROSPERO
|
|
|
2/22/21
|
Chaharom FE, Nader N | PROSPERO
|
|
|
2/22/21
|
Junior E, Júnior D | PROSPERO
|
|
|
2/22/21
|
Massimi A, Renzi E, Villari P, et al | PROSPERO
|
|
|
2/22/21
|
Marufu D, McGraw C | PROSPERO
|
|
|
2/22/21
|
Luo C, Jin J, He Q | PROSPERO
|
|
|
2/22/21
|
Xiao L, Wen S | PROSPERO
|
|
|
2/22/21
|
Mahmoud M, Mohamed EE, Ragheb R, et al | PROSPERO
|
|
|
2/22/21
|
Fond G, Boyer L, Etchecopar-Etchart D | PROSPERO
|
|
|
2/22/21
|
Mohanty R, Meher BR, Padhy BM, et al. | medRxiv
Aim: To assess the currently available data on the use of colchicine for the treatment of COVID-19. RECENTLY UPDATED
|
|
|
2/22/21
|
Chen PZ, Bobrovitz N, Premji Z, et al. | medRxiv
Aim: To analyze SARS-CoV-2 shedding dynamics across COVID-19 severity, the respiratory tract, sex and age cohorts (aged 0 to 17 years, 18 to 59 years, and 60 years or older).
|
|
|
2/22/21
|
Kremer L, Gutu R, Weyermann M | PROSPERO
|
|
|
2/22/21
|
Rostami A, Sepidarlkish M, Riahi SM, et al | PROSPERO
|
|
|
2/22/21
|
Tortosa F, Carrasco G, Ragusa M, et al. | medRxiv
Aim: To assess the effects of convalescent plasma treatment in patients with coronavirus disease (COVID-19). RECENTLY UPDATED
|
|
|
2/21/21
|
Chaudhuri M, Dhanwal AK | PROSPERO
|
|
|
2/20/21
|
Sohi I, Shield K, Chrystoja B | PROSPERO
|
|
|
2/20/21
|
Daum C, Loggers E, Khaki A | PROSPERO
|
|
|
2/19/21
|
Church K, Hall L | PROSPERO
|
|
|
2/19/21
|
Cong W, Poudel N, Alhusein N, et al. | medRxiv
Aim: To identify studies reporting antimicrobial use in the treatment of hospitalised COVID-19 patients.
|
|
|
2/19/21
|
Yadav K, Ohle R, Lukasik M | PROSPERO
|
|
|
2/19/21
|
Raga D, Salazar AF | PROSPERO
|
|
|
2/19/21
|
Cardenas-Feuntes G, Garcia-Aymerich J, Basea I Gomez M | PROSPERO
|
|
|
2/19/21
|
Abdallah B, Rahman AA, Allam S, et al | PROSPERO
|
|
|
2/19/21
|
Zaffanello M, Prefumo F, Grisolia G, et al | PROSPERO
|
|
|
2/19/21
|
Kirubarajan A, Leung S, Sobel M, et al | PROSPERO
|
|
|
2/19/21
|
Wei GX, Hao W, Qiuxia S, et al | PROSPERO
|
|
|
2/19/21
|
Carvalho I, Marambaia P | PROSPERO
|
|
|
2/18/21
|
Raina R, Chakraborty R, Mawby I, et al | PROSPERO
|
|
|
2/18/21
|
Xia Q, Gao H, Xian J, et al. | Medicine
|
|
|
2/18/21
|
Ghashghaee A, Kan FP, Raoofi S, et al | PROSPERO
|
|
|
2/18/21
|
Naciri A, Radid M, Chemsi G | PROSPERO
|
|
|
2/18/21
|
Pranata R, Wibowo A | PROSPERO
|
|
|
2/18/21
|
Seshu PN, Kachroo K, Sharma J | PROSPERO
|
|
|
2/18/21
|
Wang S, Wang J, Wang N | PROSPERO
|
|
|
2/18/21
|
Ekinci G, Çinar F | PROSPERO
|
|
|
2/17/21
|
RM K, Gopalan G, Kachroo K, et al | PROSPERO
|
|
|
2/17/21
|
Farid S, Kamel AM, Sabry N, et al | PROSPERO
|
|
|
2/17/21
|
Hu X, Wang Y, Chen J, et al. | Research Square
Aim: To evaluate the evidence behind claims that Chinese Herbal Medicine, specifically “three medicines and three formulations” (3M3F, comprising Jinhua Qinggan, Lianhua Qingwen, Xuebijing, Qingfei Paidu, Huashi Baidu and Xuanfei Baidu), is an effective treatment for COVID-19.
|
|
|
2/17/21
|
Antony S, Vargese SS, Idikula MJ, et al | PROSPERO
|
|
|
2/17/21
|
Zizzo J, Vicini D | PROSPERO
|
|
|
2/17/21
|
Dong Z, Yang L | PROSPERO
|
|
|
2/17/21
|
AlvesVP, Casemiro FG, Araujo BG, et al. | Preprints
Aim: To evaluate the factors associated with mortality of elderly Brazilians and Italians diagnosed with the new coronavirus who resided in institutions or who were hospitalized as a result of the disease. RECENTLY UPDATED
|
|
|
2/17/21
|
Mohd Nordin NR, Arsad FS, Megat Kamaruddin PSN, et al | PROSPERO
|
|
|
2/17/21
|
Dupraz J, Le Pogam MA, Peytremann-Bridevaux I | PROSPERO
|
|
|
2/17/21
|
Colonetti T, da Rosa MI, Ferreira L, et al | PROSPERO
|
|
|
2/17/21
|
Sungur S, Metinta? S, Oktar D, et al | PROSPERO
|
|
|
2/17/21
|
Staibano P, Sommer D, McHugh T | PROSPERO
|
|
|
2/17/21
|
Seaborn K, Chignell M, Gwizdka J | PROSPERO
|
|
|
2/17/21
|
Proulx K, Lenzi-Weisbecker R, Rachel R, et al. | medRxiv
Aim: To review the emerging research on nurturing care for young children during the COVID-19 crisis.
|
|
|
2/17/21
|
Hassanpour S, Arab-Zozani M, Amani B, et al. | medRxiv
Aim: To investigate the efficacy and safety of Favipiravir in the treatment of COVID-19 patients through a systematic review and meta-analysis.
|
|
|
2/17/21
|
Bedoya JPP, Muñoz AM, Barengo NC, et al | PROSPERO
|
|
|
2/16/21
|
Tan RQ, Li WTV, Shum W, et al. | Research Square
Aim: To conduct a systematic review and meta-analysis of peer-reviewed articles, which described clinical data of smell disturbances and OD in COVID-19 patients.
|
|
|
2/16/21
|
Watts K, Alexander E, O'Connor M | PROSPERO
|
|
|
2/16/21
|
Godino L, Gazineo D, Regano D, et al | PROSPERO
|
|
|
2/16/21
|
Blumenfeld O, Miller A, Niv Y, et al | PROSPERO
|
|
|
2/16/21
|
da Silva MDP, Paes LT, de Freitas Rocha AR, et al | PROSPERO
|
|
|
2/16/21
|
de Deus e Mello LM, dos Santos RC, de Albuquerque PC | PROSPERO
|
|
|
2/16/21
|
Nik Hashin NHH, Islam MA, Deris AA, et al | PROSPERO
|
|
|
2/16/21
|
Ghashghaee A, Rezaei S, Hosseinipalangi Z, et al | PROSPERO
|
|
|
2/16/21
|
Hannah J, Buazon AD, Galloway J, et al | PROSPERO
|
|
|
2/16/21
|
Viner R, Russell S, Saulle R, et al. | medRxiv
Aim: To review the evidence on the impacts of school closures on the health, wellbeing and educational outcomes of children and young people. RECENTLY UPDATED
|
|
|
2/16/21
|
Ramos K, Laporte L | PROSPERO
|
|
|
2/16/21
|
Yeh PT, Kennedy C, Narasimhan M | PROSPERO
|
|
|
2/16/21
|
Bhanu C, Gopal D, Walters K, et al | PROSPERO
|
|
|
2/16/21
|
Urabe F, Kimura S | PROSPERO
|
|
|
2/16/21
|
Lühnen J, Schmaderer C, PD, et al | PROSPERO
|
|
|
2/16/21
|
Massachi J, Kelly D, Donohue K | PROSPERO
|
|
|
2/16/21
|
Ibrahimi N, Delaunay-Moisan A, Hill C, et al. | medRxiv
Aim: To compare saliva and nasopharyngeal/oropharyngeal samples for the detection of SARS-CoV-2.
|
|
|
2/16/21
|
Bravo P, Fernandez L, Russo M, et al | PROSPERO
|
|
|
2/16/21
|
Duffy N, Whitehall L, Gorska S, Maciver D, et al | PROSPERO
|
|
|
2/16/21
|
Ekinci G, Çinar F | PROSPERO
|
|
|
2/15/21
|
| PROSPERO
|
|
|
2/15/21
|
Crankson S, Pokhrel S, Anokye NK | PROSPERO
|
|
|
2/15/21
|
Sánchez-Velazco DF, Reategui S, Zegarra-Rodríguez CA, et al | PROSPERO
|
|
|
2/15/21
|
Fernandes G, Fernandes J, Couto P | PROSPERO
|
|
|
2/15/21
|
Zaytoun P, Jhinger H, Cannon M | PROSPERO
|
|
|
2/15/21
|
Kurniawan RB, Octaviana DS, Nur Imania HA, et al | PROSPERO
|
|
|
2/15/21
|
Pakzad R, Soltani S, Malekifar P | PROSPERO
|
|
|
2/15/21
|
Hughes MC, Liu Y, Baumbach A | PROSPERO
|
|
|
2/15/21
|
Ganguly U, Mondal R, Deb S, et al | PROSPERO
|
|
|
2/15/21
|
Is there relationship between low body fat and severity of COVID-19 in athletes? A systematic review
Guimarães NS, Fausto MA | PROSPERO
|
|
|
2/15/21
|
Simha S, Bicket M, Ahmed Y | PROSPERO
|
|
|
2/15/21
|
Wright K, Lane D, Bateman L, et al | PROSPERO
|
|
|
2/15/21
|
Chen CH, Wang CY, Lai CC, et al | PROSPERO
|
|
|
2/15/21
|
Sagris D, Florentin M, Ntaios G, et al | PROSPERO
|
|
|
2/12/21
|
Hendrick L, Hickey D | PROSPERO
|
|
|
2/12/21
|
Palmer J, Pearce-Smith N, Duval D, et al | PROSPERO
|
|
|
2/12/21
|
Zorko D, Choong K, McNally JD, et al | PROSPERO
|
|
|
2/12/21
|
Monteiro AM, Lopes S, Moura C | PROSPERO
|
|
|
2/12/21
|
McGlynn N, Fazli G, Bhatia D, et al | PROSPERO
|
|
|
2/12/21
|
Pecoraro V, Negro A, Trenti T | PROSPERO
|
|
|
2/12/21
|
Kruse C, Heinemann K | PROSPERO
|
|
|
2/12/21
|
Longley B, Nord C, Dalgleish T, et al | PROSPERO
|
|
|
2/12/21
|
Mian A, Cummins C, Shamim I | PROSPERO
|
|
|
2/12/21
|
Prakash J, Khan MS, Tudu LC, et al | PROSPERO
|
|
|
2/12/21
|
Adesanya A, Rankin J, Jessica MR, et al | PROSPERO
|
|
|
2/12/21
|
Tian Y, Lu H, Zhang P, Liu X | PROSPERO
|
|
|
2/12/21
|
McGlynn N, Fazli, Bhatia D, et al | PROSPERO
|
|
|
2/12/21
|
Taype-Rondan A, Hilario-Gomez MM, Quijano-Escate, et al | PROSPERO
|
|
|
2/12/21
|
Funakoshi K, Morita T | PROSPERO
|
|
|
2/11/21
|
van Werkhoven CH, ter Schure J, Bonten MJM, et al | PROSPERO
|
|
|
2/11/21
|
Kite C, Randeva H, Kyrou I, McGregor G, | PROSPERO
|
|
|
2/11/21
|
Ocan M, Kawala BA, Kisangala E, et al. | Research Square
|
|
|
2/11/21
|
Cobos D, Nichols E, Kristen P, et al | PROSPERO
|
|
|
2/11/21
|
Kalin A, Javid B, Knight M, et al. | Research Square
Aim: To summarise the literature on the performance of different rapid tests for exertional desaturation.
|
|
|
2/11/21
|
Rahayu YS, Anggriani A, Habibie H, et al | PROSPERO
|
|
|
2/11/21
|
Pannuti CM, dos Reis INR, Silveira MLS, et al | PROSPERO
|
|
|
2/11/21
|
Zhu N, Price J, Abbas M, et al | PROSPERO
|
|
|
2/11/21
|
van Hattum JC, Spies JL, Verwijs SM, et al | PROSPERO
|
|
|
2/11/21
|
Najt P, Richards HL, Fortune D | PROSPERO
|
|
|
2/11/21
|
Mayr V, Gartlehner G, Glechner A, et al | PROSPERO
|
|
|
2/11/21
|
Ghashghaee A, Kan FP, Raoofi S, et al | PROSPERO
|
|
|
2/11/21
|
Ghashghaee A, Rezaei S, Hosseinipalangi Z, et al | PROSPERO
|
|
|
2/11/21
|
Bright K, Devoe D, Dimitropoulos G, et al | PROSPERO
|
|
|
2/10/21
|
Harmon J, Guilhermino M, Ritruechai S, et al | PROSPERO
|
|
|
2/10/21
|
Sadana D, Ayala AP, Fowler R, et al | PROSPERO
|
|
|
2/10/21
|
Mathias EG, Anupama DS, Nayak BS, et al | PROSPERO
|
|
|
2/10/21
|
Jamal RF, Chakraborthy T | PROSPERO
|
|
|
2/10/21
|
Johnston B, Dönmez ÇF, Mayland C, et al | PROSPERO
|
|
|
2/10/21
|
Chow R, Im J, Chiu N, et al. | medRxiv
Aim: To conduct a systematic review and meta-analysis to report on adverse outcomes among COVID-19 patients by statin usage.
|
|
|
2/9/21
|
Marshall-Andon T, Berger-Gillam T, Walsh S, et al | PROSPERO
|
|
|
2/9/21
|
Mezarina Mendoza JPI, Salcedo Bolívar GT, Castañeda Palacios RDP, et al | PROSPERO
|
|
|
2/9/21
|
Alza-Arcila J, Cajamarca-Baron K, Guavita-Navarro D | PROSPERO
|
|
|
2/9/21
|
Omrani O, Sheppard H, Tleyjeh I, et al | PROSPERO
|
|
|
2/9/21
|
Figueiredo K, Corrêa K, Silva F | PROSPERO
|
|
|
2/9/21
|
Wei SQ, Bertrand MB, Liu S, et al | PROSPERO
|
|
|
2/9/21
|
Haghpanah S, Hosseini-Bensenjan M, Karimi M, et al | PROSPERO
|
|
|
2/9/21
|
Fujita-Rohwerder N, Zens Y, Beckmann L, et al | PROSPERO
|
|
|
2/9/21
|
Liu M, Wang Z, Lu T | PROSPERO
|
|
|
2/9/21
|
Chen MB, Wang H, Zheng QH, et al | PROSPERO
|
|
|
2/9/21
|
Kunutsor S, Seidu S, Khunti K | PROSPERO
|
|
|
2/9/21
|
Easom N, Mason P, Shah R, et al | PROSPERO
|
|
|
2/9/21
|
Tran TH, Pelland-Marcotte MC | PROSPERO
|
|
|
2/9/21
|
Xin W, Chen S, Dong S | PROSPERO
|
|
|
2/9/21
|
Domingo FR, Garcia AJ, Boland L, et al | PROSPERO
|
|
|
2/9/21
|
Kayi I, Madran B, Keske ?, et al | PROSPERO
|
|
|
2/9/21
|
de Pinho LG, Fonseca C, do Céu Marques M, et al | PROSPERO
|
|
|
2/9/21
|
Bellinato F, Gisondi P | PROSPERO
|
|
|
2/8/21
|
Della Valle PG, Nucci D, Bonaccio M, et al | PROSPERO
|
|
|
2/8/21
|
Zeng N, Bao Y, Li C, et al | PROSPERO
|
|
|
2/8/21
|
Ferket B, Dijk S, Klein S, et al | PROSPERO
|
|
|
2/8/21
|
Chua EX, Abosamak MF, Mohd Zahir SMIS, et al | PROSPERO
|
|
|
2/8/21
|
Zhang S, Chen Z | PROSPERO
|
|
|
2/8/21
|
Li Y, Zhang J, Li S, et al. | Medicine
|
|
|
2/8/21
|
Jawaid A, Raison N | PROSPERO
|
|
|
2/8/21
|
El-Ramly T, Raut A, Ibrahim Y, et al | PROSPERO
|
|
|
2/8/21
|
Zhang XM, Wu X | PROSPERO
|
|
|
2/8/21
|
Zhang M, Wang S, Hu T, et al. | medRxiv
Aim: To better understand the role of human mobility in the COVID-19 pandemic.
|
|
|
2/8/21
|
Robinson R, Prakash V | PROSPERO
|
|
|
2/8/21
|
Galanis P, Vraka I, Fragkou D, et al. | medRxiv
Aim: To assess the impact of PPE use on HCWs’ physical health during the COVID-19 pandemic. UPDATED
|
|
|
2/8/21
|
Mitra S, Ling RR, Tan CS, et al | PROSPERO
|
|
|
2/8/21
|
Kannan S, Khanna P, Sarkar S | PROSPERO
|
|
|
2/8/21
|
Bikkannavar P, Ali Y, Angus-Leppan H | PROSPERO
|
|
|
2/8/21
|
Amarasekera AT, Li C, C. Raina M, et al | PROSPERO
|
|
|
2/8/21
|
Wang HR, Fu XY, Meng D, et al | PROSPERO
|
|
|
2/8/21
|
Systematic review of SARS-CoV-2 genetic variants characterization reported in the current literature
Chaparro Solano HM, Ruiz-Sternberg AM, Pinzon-Rondon AM, et al | PROSPERO
|
|
|
2/8/21
|
Zhu X, Luo Z, Chen Y, et al. | Medicine
|
|
|
2/8/21
|
Beukes E, Manchaiah V, Ulep A, et al | PROSPERO
|
|
|
2/8/21
|
Oton T, Carmona L | PROSPERO
|
|
|
2/5/21
|
Harwood R, Kenny S, Smith CT, et al | PROSPERO
|
|
|
2/5/21
|
Delanerolle G, Hapangama D, Shi JQ, et al | PROSPERO
|
|
|
2/5/21
|
Delanerolle G, Shetty A, Shi JQ, et al | PROSPERO
|
|
|
2/5/21
|
Wei GX, Hao W, Qiuxia S, et al | PROSPERO
|
|
|
2/5/21
|
Wei GX, Hao W, Qiuxia S, et al | PROSPERO
|
|
|
2/5/21
|
Jimenez-Cebrian AM, Garcia-Podadera B, Castro-Mendez A | PROSPERO
|
|
|
2/5/21
|
Chiu L, Chow R, Chiu N, et al. | medRxiv
Aim: To report on the state of the current literature on the use of colchicine in COVID-19 and to investigate the reported clinical outcomes in COVID-19 patients by colchicine usage.
|
|
|
2/5/21
|
Yang J, Shah P | PROSPERO
|
|
|
2/5/21
|
Raygoza-Cortez K, Saenz-Flores M, Flores-Rodriguez A, et al | PROSPERO
|
|
|
2/5/21
|
Rotshild V, Matok I, Raccah BH | PROSPERO
|
|
|
2/5/21
|
Azizi S, Taghizadeh S, Montazeri F, et al | PROSPERO
|
|
|
2/5/21
|
Donkor A, Atuwo-Ampoh VD, Opie C, et al. | Research Square
Aim: To identify strategies adopted by radiotherapy centres in low and middle-income countries (LMICs) to mitigate the effects of COVID-19.
|
|
|
2/5/21
|
One Year of Evidence on Mental Health in the COVID-19 Crisis - A Systematic Review and Meta-Analysis
 Chen X, Chen J, Zhang M, et al. | medRxiv
Aim: To review the evidence on the prevalence rate of mental health issues of the major population, including general population, general healthcare workers (HCWs), and frontline healthcare workers (HCWs), in China over one year of the COVID-19 crisis. UPDATED
|
|
|
2/5/21
|
Mora PPM, Begle C, Chen C, et al | PROSPERO
|
|
|
2/5/21
|
Gattas S, O'Reilly F, Scerif G | PROSPERO
|
|
|
2/5/21
|
Gupta A, Ovenden C | PROSPERO
|
|
|
2/5/21
|
Wei GW, Hao W, Ning L, et al | PROSPERO
|
|
|
2/5/21
|
Zhao Y, Yin L, Patel J, et al. | Research Square
Aim: To characterize inflammatory markers of MIS-C patients with COVID-19, Kawasaki disease (KD), and coronary artery abnormalities.
|
|
|
2/5/21
|
Pentecost H, Lewis A | PROSPERO
|
|
|
2/5/21
|
Trott M, Pardhan S, Vaughan M | PROSPERO
|
|
|
2/4/21
|
Schwendinger F, Infanger D, Schmidt-Trucksass A | PROSPERO
|
|
|
2/4/21
|
Comparison of efficacy and safety of different vaccines to prevent COVID-19: a network meta-analysis
Panunzi S, Maltese S, Mingrone G, et al | PROSPERO
|
|
|
2/4/21
|
Qing X, Xu W, Zhang Y | PROSPERO
|
|
|
2/4/21
|
Stevanato KP, da Silva VL, Silva GM, et al | PROSPERO
|
|
|
2/4/21
|
Kabbani D, Sonpar A, Benson W, et al | PROSPERO
|
|
|
2/4/21
|
Minchin J, Smith E | PROSPERO
|
|
|
2/4/21
|
Tegegne K, Wagnaw F, Eyayu D | PROSPERO
|
|
|
2/4/21
|
Hoshi K, Ikebe T, Ota Y, et al | PROSPERO
|
|
|
2/4/21
|
Sevillano SB, Fernandez MF, Vasquez-Vertiz D, et al | PROSPERO
|
|
|
2/4/21
|
Amer Y, Minhas M, Alkhamis W, et al | PROSPERO
|
|
|
2/4/21
|
Dong F, Lv Y, Ji X, et al | PROSPERO
|
|
|
2/4/21
|
Prabani KIP, HDWT Damayanthi Dassanayake | PROSPERO
|
|
|
2/4/21
|
Su Z, McDonnell D, Liang B, et al. | Syst Rev
|
|
|
2/4/21
|
Faical A, Ramos R, Souza E, et al | PROSPERO
|
|
|
2/4/21
|
Katsura C, Kankam H, Hourston G, et al | PROSPERO
|
|
|
2/4/21
|
Hanrahan C, Peetluck L, Golub J | PROSPERO
|
|
|
2/4/21
|
Wafa IA, Pramtama NR, Budi DS, et al | PROSPERO
|
|
|
2/4/21
|
Zhang QQ, Zhong BL, Li HM, et al | PROSPERO
|
|
|
2/4/21
|
Ghasemian R, Shamshirian A, Heydari K, et al. | medRxiv
Aim: To review the evidence on the role of vitamin D in COVID-19.
|
|
|
2/4/21
|
Nyberg A, Rajaleid K, Demmelmaier I | PROSPERO
|
|
|
2/3/21
|
Kiran S, Sevim F | PROSPERO
|
|
|
2/3/21
|
Vijayan M, Kilivanan ANH | PROSPERO
|
|
|
2/3/21
|
Ngan GYK, Ng KY, Wong KH, et al | PROSPERO
|
|
|
2/3/21
|
Tian X, Ying R, Zhang C, et al | PROSPERO
|
|
|
2/3/21
|
Szako L, Farkas N, Kiss S, et al. | Trials
|
|
|
2/3/21
|
Nafea A, Mahmoud A, Elanany I, et al | PROSPERO
|
|
|
2/3/21
|
Cilar L, Stiglic G | PROSPERO
|
|
|
2/3/21
|
Hill A, Heath K, Garratt A, et al | PROSPERO
|
|
|
2/3/21
|
Nayak A, Siddharth KK, Ashwini DL, et al | PROSPERO
|
|
|
2/3/21
|
Hoang MP Snidvongs K, Sommer D, et al | PROSPERO
|
|
|
2/3/21
|
Klassen SA, Senefeld J, Johnson PW, et al. | medRxiv
Aim: To determine the effect of COVID-19 convalescent plasma on mortality.
|
|
|
2/2/21
|
Rao N, Kim J | PROSPERO
|
|
|
2/2/21
|
Rees N, Williams J, Hogan C, et al | PROSPERO
|
|
|
2/2/21
|
Cruciani M, Marano G, Mengoli C, et al | PROSPERO
|
|
|
2/2/21
|
Valencia EJD, Cardenas AC, Pintor PMR, et al | PROSPERO
|
|
|
2/2/21
|
Abedin M, Wahab A, Rahman F | PROSPERO
|
|
|
2/2/21
|
Guo X, Wang H, Li N, et al | PROSPERO
|
|
|
2/2/21
|
Chen MB, Wang H, Zheng QH, et al | PROSPERO
|
|
|
2/2/21
|
Shao T, Zhao M, Zhou D, et al | PROSPERO
|
|
|
2/2/21
|
Fong HX, Golden K, Cornish K, et al | PROSPERO
|
|
|
2/2/21
|
Park J, Lee JH | PROSPERO
|
|
|
2/2/21
|
Giuliani M, Caponio VCA | PROSPERO
|
|
|
2/2/21
|
Prediction Models for Severe Manifestations and Mortality due to COVID-19: A Rapid Systematic Review
Miller J, Tada M, Goto M, et al. | medRxiv
Aim: To evaluate published reports of prediction models for severe illnesses caused COVID-19. UPDATED
|
|
|
2/2/21
|
Ruiz M, de Oliveira K, de Oliveira J, et al | PROSPERO
|
|
|
2/2/21
|
Cao Y, Zhai Y, Hiyoshi A | PROSPERO
|
|
|
2/2/21
|
Caulley L, Schramm D, Cooper C, et al | PROSPERO
|
|
|
2/2/21
|
Witarto AP, Witarto BS, Er Putra AJ, et al | PROSPERO
|
|
|
2/2/21
|
Alnagar A, Almaghraby A | PROSPERO
|
|
|
2/2/21
|
Akbar M, Pranata R, Wibowo A, et al | PROSPERO
|
|
|
2/2/21
|
Cai C, Peng Y, Zeng S | PROSPERO
|
|
|
2/2/21
|
Liang Q, Song Q, Liang N, et al | PROSPERO
|
|
|
2/1/21
|
Rycroft C, Underwood T | PROSPERO
|
|
|
2/1/21
|
Sales-Peres S, Azevedo-Silva L, Castilho AV, et al | PROSPERO
|
|
|
2/1/21
|
Kim MS, Seong D, Li H, et al. | SSRN
Aim: To evaluate the comparative efficacy of N95, surgical/medical, and non-medical facemasks in preventing respiratory virus infection.
|
|
|
2/1/21
|
Ciapponi A, Bardach A, Comande D, et al | PROSPERO
|
|
|
2/1/21
|
Keske S, Ergönül Ö | PROSPERO
|
|
|
2/1/21
|
Indarto F, Halim FS, Tjang YS | PROSPERO
|
|
|
2/1/21
|
Wang Z, Liu H, Wu M, et al. | Research Square
Aim: To systematically review the therapeutic reports on COVID-19 treated with integrated herbal medicine “Lianhua-Qingwen”and Western medicine to evaluate the efficacy and safety of the treatment.
|
|
|
2/1/21
|
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. | medRxiv
Aim: To identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID-19 stage.
|
|
|
2/1/21
|
Bach-Mortensen A, Verboom B, Esposti MD | medRxiv
Aim: To identify, appraise, and synthesise the available research on ownership variation in COVID-19 outcomes (outbreaks, infections, deaths, shortage of personal protective equipment (PPE) and staff) across for-profit, public, and non-profit care homes for older people. UPDATED
|
|
|
2/1/21
|
Vio R, Proietti R, Andrea G, et al | PROSPERO
|
|
|
2/1/21
|
Vasquez AV, Cuevas AG, Bastidas AAR, et al | PROSPERO
|
|
|
2/1/21
|
Kalaij AGI, Dirjayanto VJ | PROSPERO
|
|
|
2/1/21
|
Wei GX, Wang H, Song Q, et al | PROSPERO
|
|
|
2/1/21
|
Snow T, Saleem N, Burns H, et al | PROSPERO
|
|
|
2/1/21
|
Bakanaite E, Rowe S, Pitman A | PROSPERO
|
|
|
1/29/21
|
Suarez-Gonzalez A, Rajagopalan J, Alladi S | PROSPERO
|
|
|
1/29/21
|
Thakur B & Pathak M | medRxiv
Aim: To assess the burden among three group of population, i.e., frontline healthcare workers (FHW), non-frontline healthcare workers (NFHW) and general who are not healthcare workers.
|
|
|
1/29/21
|
Jdiaa S, El Alayli A, Mansour R, et al | PROSPERO
|
|
|
1/29/21
|
e Souza Lopes AKKL, Apolinario TA, Kamiyama SY, et al | PROSPERO
|
|
|
1/29/21
|
Tang Z, Li M, Chen W, et al. | Medicine
|
|
|
1/29/21
|
Baral S, Rao A, Twahirwa Rwema JO, et al. | medRxiv
Aim: To characterize the impact of COVID-19 on HIV, tuberculosis, malaria, sexual and reproductive health, and malnutrition.
|
|
|
1/29/21
|
Jingyi G, Ma Y, Wu Z, et al | PROSPERO
|
|
|
1/29/21
|
Lepere P, Escarguel B, Yolartiran S, et al. | medRxiv
Aim: To address the question: Can early home treatment with AZM alone or with zinc help prevent hospitalisation, death, and long-COVID-19?
|
|
|
1/29/21
|
Milovanovic L, Hessey E, Sebastianski M, et al. | BMJ Open
Aim: To identify epidemiological factors, treatments and complications that predict mortality among critically ill patients with COVID-19.
|
|
|
1/29/21
|
Lee ZX, Ang E, Lim XT | PROSPERO
|
|
|
1/29/21
|
Palo SK, Mishra BK, Dubey S, et al | PROSPERO
|
|
|
1/29/21
|
Smith V, Flaherty J, Matvienko-Sikar K, et al | PROSPERO
|
|
|
1/29/21
|
Benedetti F, Benros ME, Branchi I, et al | PROSPERO
|
|
|
1/29/21
|
Kang Z, Yang J | PROSPERO
|
|
|
1/29/21
|
Iglesias JG, Howlett N, Breslin G, Bartington S, et al | PROSPERO
|
|
|
1/29/21
|
Grieve S, Rabe A, Matthys A, et al | PROSPERO
|
|
|
1/29/21
|
Matu J, Feeley A, Mabbs L, et al | PROSPERO
|
|
|
1/29/21
|
Wei GX, Wang H, Song Q, et al | PROSPERO
|
|
|
1/29/21
|
St Denny E, Cairney P, Mitchell H | PROSPERO
|
|
|
1/29/21
|
Ibrahim M, Osman A, Karrar K, et al | PROSPERO
|
|
|
1/29/21
|
Marconcin P, Peralta M, Ihle A, et al | PROSPERO
|
|
|
1/28/21
|
Octavius GS, Tan R, Pratama TA, et al | PROSPERO
|
|
|
1/28/21
|
Fu S, Li Z, Yuan L, et al | PROSPERO
|
|
|
1/28/21
|
Abbas K, Shah J, El-Sahat N, et al. | Research Square
Aim: To review the evidence on the clinical features and management of transplant patients with COVID-19.
|
|
|
1/28/21
|
Roshdy A, El Sayed I, Moursi F | PROSPERO
|
|
|
1/28/21
|
Digamo K, Tolossa D | PROSPERO
|
|
|
1/28/21
|
Wang Q, Zhu H, Ge L, et al | PROSPERO
|
|
|
1/28/21
|
Liu F, Tan A | PROSPERO
|
|
|
1/28/21
|
Dobbins M | National Collaborating Centre for Methods and Tools
|
|
|
1/28/21
|
Castaneda-Sabogal A, Chambergo-Michilot D, Toro-Huamanchumo CJ, et al. | medRxiv
Aim: To assess the outcomes of ivermectin in ambulatory and hospitalized patients with COVID-19.
|
|
|
1/28/21
|
Liu X, Xiao J, Wang H, et al | PROSPERO
|
|
|
1/28/21
|
Wei GX, Wang H, Song Q, et al | PROSPERO
|
|
|
1/28/21
|
Wei GX, Wang H, Song Q, et al | PROSPERO
|
|
|
1/28/21
|
Han T, Ma S, Sun C, et al. | medRxiv
Aim: To review the evidence on the anti-inflammatory effects of hypoglycemic agents in patients with diabetes and COVID-19.
|
|
|
1/28/21
|
Sun N, He Y, Han X, et al | PROSPERO
|
|
|
1/28/21
|
Subramaniam A, Lim ZJ, Ashwin S, et al | PROSPERO
|
|
|
1/28/21
|
Epton T, Byrne-Davis L, Hart J, et al | PROSPERO
|
|
|
1/27/21
|
Pavlov I, He H, McNicholas B, et al. | Research Square
Aim: To synthesize the available evidence on the efficacy of APP.
|
|
|
1/27/21
|
Andrianto A, Al-Farabi MJ, Nugraha RA, et al. | medRxiv
Aim: To assess biomarkers of endothelial cells in patients with COVID-19.
|
|
|
1/27/21
|
Luthra R, Parveen R, Bajpai R, et al | PROSPERO
|
|
|
1/27/21
|
Cherrie J, Cherrie M, Davis A, et al. | medRxiv
Aim: To evaluate the evidence for air and surface contamination of workplace environments with SARS-CoV-2 RNA and the quality of the methods used to identify actions necessary to improve the quality of the data.
|
|
|
1/27/21
|
Nopsopon T, Kittrakulrat J, Takkavatakarn K, et al. | medRxiv
Aim: To evaluate the prevalence and case fatality rate of COVID-19 in patients with ESRD with RRT.
|
|
|
1/27/21
|
Nafea A, Altaweel A, Abdelrahman A, et al | PROSPERO
|
|
|
1/27/21
|
Gonçalves RL, Gonçalves DG, Coelho TR, et al | PROSPERO
|
|
|
1/27/21
|
A-Lai GH, Xu ZJ, Lin YD | PROSPERO
|
|
|
1/27/21
|
Almeida C, Souza T, Rossetto M | PROSPERO
|
|
|
1/27/21
|
Kunzler AM, Roethke N, Linder S, et al | PROSPERO
|
|
|
1/27/21
|
Andreas M, Piechotta V, Becker G, et al | PROSPERO
|
|
|
1/27/21
|
Váncsa S, Dembrovsky F, Farkas N, et al | PROSPERO
|
|
|
1/27/21
|
Imtiaz S, Nafeh F, Russell C, et al | PROSPERO
|
|
|
1/27/21
|
Pranata R, Akbar M, Lim M, et al | PROSPERO
|
|
|
1/27/21
|
Pranata R, Akbar M, et al | PROSPERO
|
|
|
1/27/21
|
Kohli S, Menon GR, Ketharam A, et al | PROSPERO
|
|
|
1/26/21
|
Morais LSF, de Araujo GT, Lombardi LA, et al | PROSPERO
|
|
|
1/26/21
|
Almuqarrab F, Almohssen A | PROSPERO
|
|
|
1/26/21
|
Kwizera A, Rochwerg B, Kabatooro D | PROSPERO
|
|
|
1/26/21
|
Weir N, Kurdi A, Mueller T | PROSPERO
|
|
|
1/26/21
|
Kunzler AM, Roethke N, Lindner S, et al | PROSPERO
|
|
|
1/26/21
|
Lim C, Sim J | PROSPERO
|
|
|
1/26/21
|
Leon E, Lopez L, de la Pava C | PROSPERO
|
|
|
1/26/21
|
Tenawe H, Abuzuaiter I | PROSPERO
|
|
|
1/26/21
|
Fu S, Tian X, Zhang K | PROSPERO
|
|
|
1/26/21
|
Mitratza M, Goodale BM, Downward GS, et al | PROSPERO
|
|
|
1/26/21
|
Loh CH, Oh CC | PROSPERO
|
|
|
1/26/21
|
Guo C, Yi D | PROSPERO
|
|
|
1/26/21
|
Deng J, Zhou F | PROSPERO
|
|
|
1/26/21
|
Tamuzi JL, Nyasulu P, Bayele B | PROSPERO
|
|
|
1/26/21
|
Deng J, Zhou F | PROSPERO
|
|
|
1/26/21
|
Cardoso da Silva HE, Martins GN, Leite AF, et al | PROSPERO
|
|
|
1/26/21
|
Amir M, Sudharsono A, Adam ATS, et al | PROSPERO
|
|
|
1/25/21
|
Yang Q, Zhou J | PROSPERO
|
|
|
1/25/21
|
Colakar M, Erbaydar NP | PROSPERO
|
|
|
1/25/21
|
Chhibber A, Kharat A, Kneale D, et al | PROSPERO
|
|
|
1/25/21
|
Zuniga RAA, Villoria RAMG, Elizondo MV, et al. | medRxiv
Aim: To determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients with diagnosis of COVID-19.
|
|
|
1/25/21
|
Nersesjan V, Amiri M, Kondziella D | PROSPERO
|
|
|
1/25/21
|
Weibel S, Popp M, Meybohm P, et al | PROSPERO
|
|
|
1/25/21
|
Lv Y, Dong F, Fan X, et al | PROSPERO
|
|
|
1/25/21
|
Vieira da Silva AKC, Patiño Escartina JE, Souza RB, et al | PROSPERO
|
|
|
1/25/21
|
Cardelli C, Zucchi D, Figliomeni A, et al | PROSPERO
|
|
|
1/25/21
|
Goves J, Body R | PROSPERO
|
|
|
1/25/21
|
Yamamoto S, Saito M, Tamura A, et al. | SSRN
Aim: To evaluate existing evidence on the association between the microbiome and COVID-19 in humans and summarize this data in the pandemic era.
|
|
|
1/25/21
|
Deng D, Chui J, Liang A | PROSPERO
|
|
|
1/25/21
|
Organ C, Shankar R, Zabel A, et al | PROSPERO
|
|
|
1/25/21
|
Miao J, Liu Z | PROSPERO
|
|
|
1/23/21
|
San Juan NV, Camilleri M, Jeans JP, et al. | medRxiv
Aim: To provide a detailed understanding of the characteristics of redeployment to ICU and training provision during the first year of the COVID-19 pandemic.
|
|
|
1/23/21
|
Qiu X, Nergiz AI, Maraolo AE, et al. | medRxiv
Aim: To critically appraise available data about secondary attack rates from people with asymptomatic and pre-symptomatic SARS-CoV-2 infection.
|
|
|
1/23/21
|
Ngo BT, Marik P, Kory P, et al. | medRxiv
Aim: To assess the options at the present time for release of pharmacologic agents to treat and to prevent COVID-19 while pursuing widespread vaccination in 2021.
|
|
|
1/22/21
|
Li F, Li Y, Zhang J, et al. | Medicine
|
|
|
1/21/21
|
Daniali H, Flaten MA | PROSPERO
|
|
|
1/21/21
|
Hilario-Gomez MM, Pinedo-Castillo L, Zumaran-Nunez CJ, et al | PROSPERO
|
|
|
1/21/21
|
Digamo K, Tolossa D | PROSPERO
|
|
|
1/21/21
|
Nna E, Alao MA, Ogunbosi B, et al. | Research Square
|
|
|
1/21/21
|
Developing a casual framework for COVID-19 infection: a systematic review of epidemiological studies
Dill O, Slimings C, Bain-Donohue S | PROSPERO
|
|
|
1/21/21
|
Ahmed MA< Sun C, Kim NH | PROSPERO
|
|
|
1/21/21
|
Bakhtiari N, Shoushtari MH, Barfar M, et al | PROSPERO
|
|
|
1/21/21
|
Zhou Y, Xia QC, Yan X, et al | PROSPERO
|
|
|
1/21/21
|
Stroehlein JK, Wallqvist J, Iannizzi C, et al | PROSPERO
|
|
|
1/21/21
|
Huntley B, Chauhan S, Berghella V, et al | PROSPERO
|
|
|
1/21/21
|
Rajwar E, Radhakrishnan R, Pundir P, et al | PROSPERO
|
|
|
1/21/21
|
Muhammad Kamil NMN, Noor NM, Zakaria N, et al | PROSPERO
|
|
|
1/21/21
|
Patterson PD, Miller R, Martin-Gill C, et al | PROSPERO
|
|
|
1/21/21
|
Kula B, Clancy CJ, Nguyen MG, et al. | medRxiv
Aim: To review the evidence from autopsy studies performed in persons with fatal COVID-19 to determine the prevalence of autopsy-proven tissue-invasive IMD and analyze patient-level data to assess potential risk factors.
|
|
|
1/21/21
|
Weibel S, Popp M, Meybohm P, et al | PROSPERO
|
|
|
1/21/21
|
Popp M, Schmid B, Herrmann J, et al | PROSPERO
|
|
|
1/21/21
|
Huntley B, Chauhan S, Mulder I, et al | PROSPERO
|
|
|
1/21/21
|
Pamungkas KMN, Lesmana Dewi PIS, | PROSPERO
|
|
|
1/20/21
|
Luo Y, Jan DR, Zheng M, et al | PROSPERO
|
|
|
1/20/21
|
Liu X, Lu L, Li X, et al | PROSPERO
|
|
|
1/20/21
|
Brogi E, Marino F | PROSPERO
|
|
|
1/20/21
|
Xun Y, Ren M, Wang P, et al | PROSPERO
|
|
|
1/20/21
|
Moreira V, Masarenhas P, Machado V, et al. | medRxiv
Aim: To critically appraise and compare the clinical performance of RT-PCR tests using oral saliva, deep-throat saliva/ posterior oropharyngeal saliva (DTS/POS), sputum, urine, feces, and tears/conjunctival swab [CS]) against standard specimens (NPS, OPS, or a combination of both). UPDATED
|
|
|
1/20/21
|
Dhital R, Shah R, Shrestha C, et al | PROSPERO
|
|
|
1/20/21
|
Minkove S, Torabi-Parizi P, Eichacker P, et al | PROSPERO
|
|
|
1/20/21
|
Lange B, Ott J, Karki J | PROSPERO
|
|
|
1/20/21
|
Preston N, Briggs L, Rocks P, et al | PROSPERO
|
|
|
1/20/21
|
Shanmugam C, Behring M, Luthra V, et al. | medRxiv
Aim: To identify reasons for variability in COVID-19 diagnostic tests in the early phase of the pandemic that might have contributed to the spread of COVID-19.
|
|
|
1/20/21
|
Luo Y, Jan DR, Zhang M, et al | PROSPERO
|
|
|
1/20/21
|
Morales-Cane I, Lopez-Soto PJ, de los Reyes Fernandez-Vega M | PROSPERO
|
|
|
1/20/21
|
Ryan B, Kirk M, Boland F, et al | PROSPERO
|
|
|
1/20/21
|
Brehmer C, Todkil D, Edeghere O | PROSPERO
|
|
|
1/20/21
|
Martha J, Pranata R, Lim M | PROSPERO
|
|
|
1/20/21
|
Silveira V, Viola P, Carvalho C, Nunes A | PROSPERO
|
|
|
1/19/21
|
Timpka T, Joud A, Spreco A, et al | PROSPERO
|
|
|
1/19/21
|
Elgendy IY, Elbadawi A | PROSPERO
|
|
|
1/19/21
|
Bhattacharyya A, Seth A, Srivastava N, et al. | Research Square
Aim: To summarize COVID-19’s impact based on symptoms, demographics, comorbidities, and demonstrates the association of demographics in cases and mortality in the United States.
|
|
|
1/19/21
|
Lee SG, Fralick M, Tang G, et al. | medRxiv
Aim: To describe the relationship between hemostatic laboratory parameters and important clinical outcomes among adults with COVID-19.
|
|
|
1/19/21
|
Chen K, Yunusa I, Liu S, et al. | Preprints
Aim: To provide up-to-date qualitative and quantitative evidence of the epidemiology, clinical characteristics, laboratory data, and test the hypothesis that the distribution of symptoms, comorbidities, and severity would be different among patients different age groups, countries, and stages of outbreak. UPDATED
|
|
|
1/19/21
|
Yao H, Peng J, Zheng X, et al. | Research Square
Aim: To comprehensively review the available evidence identify the effectiveness and safety of remdesivir in patients with COVID-19.
|
|
|
1/19/21
|
Lipworth S, Rigby I, Cheng V, et al. | medRxiv
Aim: To assess the responsiveness and quality of clinical management guidelines (CMGs) in SARS, MERS and COVID-19 and determine whether this has improved over time.
|
|
|
1/19/21
|
Mbwogge M | medRxiv
Aim: To evaluate the effectiveness of mass testing and contact tracing in the suppression of COVID-19 compared to conventional Test and Trace in the UK.
|
|
|
1/19/21
|
Budhathoki P, Shhrestha D, Raut S, et al | PROSPERO
|
|
|
1/19/21
|
Azami-Aghdash S, Naghibi D, Khairy Y | PROSPERO
|
|
|
1/19/21
|
Tonapa SI, Saragih ID, Lee BO | PROSPERO
|
|
|
1/19/21
|
Mohsenpour A, Bozorgmehr K, Rohleder S, et al. | medRxiv
Aim: To synthesise the evidence on SARS-Cov-2 infection, transmission, outcomes of disease, effects of non-pharmaceutical interventions (NPI), and the effectiveness of targeted strategies for infection prevention and control (IPC).
|
|
|
1/19/21
|
Noureldin A, Othman M, Kazi S | PROSPERO
|
|
|
1/19/21
|
Panchal U, de Pablo GS, Moreno C, et al | PROSPERO
|
|
|
1/19/21
|
Sarkar S, Kannan S, Khanna P, et al | PROSPERO
|
|
|
1/19/21
|
Liang M, Chen M, Singh S, et al | PROSPERO
|
|
|
1/19/21
|
Shi S, Huang D, Wang F, et al | PROSPERO
|
|
|
1/19/21
|
Tocilizumab therapy on COVID-19 patients mortality rate: a systematic review and meta-analysis study
Corbi G, Conti V | PROSPERO
|
|
|
1/18/21
|
A systematic review on mental health problems among nurses taking care of COVID 19 positive patients
Saini SK, Kalyan G, Dandapani M, et al | PROSPERO
|
|
|
1/18/21
|
Gonçalves RL, Silva de França NE, da Silva LN, et al | PROSPERO
|
|
|
1/18/21
|
Wu K, Zhang M, Zhou X | PROSPERO
|
|
|
1/18/21
|
Pal R, Mukherjee S, Bhadada SK, et al | PROSPERO
|
|
|
1/18/21
|
Emara M, Alboraie M, Mahros A, et al | PROSPERO
|
|
|
1/18/21
|
Belletti A, Landoni G, Zangrillo A | PROSPERO
|
|
|
1/18/21
|
Longo M, Anomneze-Collins A, Mann M, et al | PROSPERO
|
|
|
1/18/21
|
Belletti A, Valsecchi G, Todaro G, et al | PROSPERO
|
|
|
1/18/21
|
Zhou C, Lou B, Duan F | PROSPERO
|
|
|
1/18/21
|
Tumminaro A, Favilla V | PROSPERO
|
|
|
1/18/21
|
Gonçalves RL, Lima GF, da Silva LN, et al | PROSPERO
|
|
|
1/16/21
|
LoCurto J, Lange BCL, Chang R, et al | PROSPERO
|
|
|
1/15/21
|
Papadopoulos VP, Koutroulos M, Zikoudi D, et al. | medRxiv
Aim: To provide further evidence regarding the key features of COVID-19-related acute metabolic emergencies in diabetes (DKA, EDKA, HHS, and DKA/HHS) by identifying all relevant case reports that can provide detailed patient data and summarizing their results together.
|
|
|
1/15/21
|
Obrero-Gaitan E, Lomas-Vega R, Cortes-Perez I | PROSPERO
|
|
|
1/15/21
|
Dogheim G, Abdel-Aziz E, Aboukhatwa M, et al | PROSPERO
|
|
|
1/15/21
|
Robinson E, Jones A, Daly M, et al | PROSPERO
|
|
|
1/15/21
|
Bello U, Mahmud FA, Jalo HA, et al | PROSPERO
|
|
|
1/15/21
|
Avci YD, Gozum S | PROSPERO
|
|
|
1/15/21
|
Fanti E, Milesi A | PROSPERO
|
|
|
1/15/21
|
Guo Q, Song Y, Ma L, et al | PROSPERO
|
|
|
1/15/21
|
Reis L, Santos E, Pimenta G, et al | PROSPERO
|
|
|
1/15/21
|
Li F, Liang W, Shang B, et al | PROSPERO
|
|
|
1/15/21
|
Liu L, Ni SY | PROSPERO
|
|
|
1/15/21
|
Williams J, Goulding L, Jordan H, et al | PROSPERO
|
|
|
1/15/21
|
Franco CHC, Ospina N, Bermudez IS | PROSPERO
|
|
|
1/15/21
|
Lee M, Shin J | PROSPERO
|
|
|
1/15/21
|
Ji Y, Qiu G, Song D, et al. | Medicine
|
|
|
1/15/21
|
Snow T, Saleem N, Singer M, et al | PROSPERO
|
|
|
1/15/21
|
Li S, Zhang J, Li F, et al. | Medicine
|
|
|
1/15/21
|
Said J, Perez-Chada L, Elman S, et al | PROSPERO
|
|
|
1/14/21
|
Vale C, Sterne J, Tierney J, et al | PROSPERO
|
|
|
1/14/21
|
| CADTH
|
|
|
1/14/21
|
Wendt GW, Ferreto L, Ximenez J, et al | PROSPERO
|
|
|
1/14/21
|
Beaudart C, Diep AN, Locquet M, et al | PROSPERO
|
|
|
1/14/21
|
Gonçalves AK, Medeiros K, Sarmento A, et al | PROSPERO
|
|
|
1/14/21
|
Li Y, Yang JZ, Li ZY | PROSPERO
|
|
|
1/13/21
|
Ghahramani S, Azmand S, Shahabi S | PROSPERO
|
|
|
1/13/21
|
Hashan MR, Smoll N, King C, et al | PROSPERO
|
|
|
1/13/21
|
Eshetie S, Vinery K, Gray D | PROSPERO
|
|
|
1/13/21
|
Yonenaga K, Itai S, Hoshi K | PROSPERO
|
|
|
1/12/21
|
Papadopoulos V, Koutroulos MV, Avramidou P, et al. | PROSPERO
|
|
|
1/12/21
|
Octavius GS, Chandra S, Wijaya JH, et al. | PROSPERO
|
|
|
1/12/21
|
Yetmar Z, Tleyjeh I, Chesdachai S | PROSPERO
|
|
|
1/12/21
|
Udoh A, Akpan M, Olojo I, et al. | PROSPERO
|
|
|
1/12/21
|
Li C, Islam N, Gutierrez JP, et al. | PROSPERO
|
|
|
1/12/21
|
Herrera AM, Cortes K, Estrada-Orozco K | PROSPERO
|
|
|
1/12/21
|
Samaranayake L, Fakhruddin K, Ngo H, et al. | PROSPERO
|
|
|
1/12/21
|
Nowroozi A, Karimi A, Alilou S, et al. | PROSPERO
|
|
|
1/12/21
|
Tu J, Xie T, Zhang X, et al. | PROSPERO
|
|
|
1/12/21
|
Benites-Meza JK, Mamani-Garcia CS, Bustamante-Paytan D, et al. | PROSPERO
|
|
|
1/12/21
|
Sarma P, Bhattacharyya A, Kaur H, et al. | PROSPERO
|
|
|
1/12/21
|
Turki A, Abbas KS, Makram AM, et al. | PROSPERO
|
|
|
1/12/21
|
Rivera-Ramierz P, Fiestas-Saldarriaga F, Nys BL | PROSPERO
|
|
|
1/12/21
|
Chan YY, Rahman ZA, Harun A, et al. | PROSPERO
|
|
|
1/12/21
|
Romiti GF, Proietti M | PROSPERO
|
|
|
1/12/21
|
Hoshijima H, Mihara T, Seki H, et al. | PROSPERO
|
|
|
1/12/21
|
Romiti GF, Corica B | PROSPERO
|
|
|
1/12/21
|
Hariyanto TI, Rosalind J, Halim DA, et al. | PROSPERO
|
|
|
1/12/21
|
Reyad O, Ghazy R, El-Deen AN, Alaa N, et al. | PROSPERO
|
|
|
1/12/21
|
Li P, Xu A, Li M, et al. | PROSPERO
|
|
|
1/12/21
|
Papadopoulos V, Avramidou P, Bakola S, et al. | medRxiv
Aim: To provide further evidence regarding the mortality rate in COVID-19-related acute metabolic emergencies (DKA, HHS, combined DKA/HHS, and EDKA) by identifying all relevant studies and summarize their results. UPDATED
|
|
|
1/12/21
|
Kumar A, Kumar D V, Sharma A, et al. | PROSPERO
|
|
|
1/12/21
|
Ridjab DA, Ivan I, Budiman F, et al. | PROSPERO
|
|
|
1/12/21
|
Udoh A, Akpan M, Kpokiri E, et al. | PROSPERO
|
|
|
1/12/21
|
Imani-Nasab MH, Hashemi S, Bajoulvand R, et al. | PROSPERO
|
|
|
1/12/21
|
Khan S, Haleem MH | PROSPERO
|
|
|
1/12/21
|
Ogungbe B, Asala A, Kumbe B, et al. | PROSPERO
|
|
|
1/12/21
|
Lee B, Chen X, Yu G, et al. | PROSPERO
|
|
|
1/12/21
|
Pereira AM, da Silveira Moreira R, Adagilson, et al. | PROSPERO
|
|
|
1/12/21
|
Fiocca V, Suen V | PROSPERO
|
|
|
1/12/21
|
Czakert JP, Ballesteiros GP, Berger R | PROSPERO
|
|
|
1/12/21
|
Iuo C, Huang L, Zhao F, et al. | PROSPERO
|
|
|
1/12/21
|
Huang I, Wijaya I, Andhika R | PROSPERO
|
|
|
1/12/21
|
Yi T, Peng W, Tu | PROSPERO
|
|
|
1/12/21
|
Khodakarami N, Olatunki E, Kassabian M | PROSPERO
|
|
|
1/11/21
|
Singh A, Yadav M, Sankar J | PROSPERO
|
|
|
1/11/21
|
Kariyawasam R, Dingle T, Chen J, et al. | PROSPERO
|
|
|
1/11/21
|
Berg K, Hsu C, Considine J, Pawar R, et al. | PROSPERO
|
|
|
1/11/21
|
Zhan T, Chen H, Li Y | PROSPERO
|
|
|
1/11/21
|
Gonçalves RL, Pereira Lopes TC, Cordeiro SA, et al. | PROSPERO
|
|
|
1/11/21
|
Aggarwal AM, Agarwal R, Dhooria S, et al. | PROSPERO
|
|
|
1/11/21
|
Aggarwal AN, Agarwal R, Dhooria S, et al. | PROSPERO
|
|
|
1/11/21
|
Kojima A, Nisijima C, Sato Y, et al. | PROSPERO
|
|
|
1/11/21
|
Gonçalves AK, Medeiros K, Sarmento A, et al. | PROSPERO
|
|
|
1/11/21
|
Kirkham A, Allan D, Shorr R, et al. | PROSPERO
|
|
|
1/11/21
|
Dowsett L, Clement F, Tricco A, et al. | PROSPERO
|
|
|
1/11/21
|
Johns G, Waddington L, Samuel V | PROSPERO
|
|
|
1/11/21
|
Santos J, Fernandes A, Maia L, et al. | PROSPERO
|
|
|
1/11/21
|
Gates M, Pillay J, Wingert A, et al. | PROSPERO
|
|
|
1/11/21
|
Farias GS, Nascimento Salazar TC, Barros GR | PROSPERO
|
|
|
1/11/21
|
Wang Y, Tian X, Liu B, et al. | PROSPERO
|
|
|
1/11/21
|
Jiang L, Li Y, Feng X | PROSPERO
|
|
|
1/10/21
|
da Silva Kist MLO, Drumond Costa CA, Ramos Garcia PC, et al. | PROSPERO
|
|
|
1/9/21
|
Sriharan A, Ratnapalan S, Tricco AC, et al. | medRxiv
Aim: To identify the causes of occupational stress and burnout in women in medicine, nursing, and other health professions during the COVID-19 pandemic and interventions that can support female health professionals deal with this crisis through a rapid review.
|
|
|
1/8/21
|
Delanerolle G, Shi J, Ramakrishnan R, Phiri P | PROSPERO
|
|
|
1/8/21
|
Kant R, Yadav P, Khapre M | PROSPERO
|
|
|
1/8/21
|
Atmaja S, Kristiyani A, Yuhara N | PROSPERO
|
|
|
1/8/21
|
Moron-Duarte LS, Yomayusa N, Chacon Acevedo KR, et al | PROSPERO
|
|
|
1/8/21
|
Fitzpatrick J, Ezhova I, Hussein S, et al | PROSPERO
|
|
|
1/8/21
|
Dettmann LM, Taylor G | PROSPERO
|
|
|
1/8/21
|
Tsivgoulis G, Katsanos A, Fragkou P, et al | PROSPERO
|
|
|
1/8/21
|
La Verde M, Licciardi F, Scida S, et al | PROSPERO
|
|
|
1/8/21
|
Zhang J, Wang Y | PROSPERO
|
|
|
1/8/21
|
Zhou C, Pei H, Gao Y, et al. | BMJ Open
|
|
|
1/8/21
|
Zhu Z, Mao Y, Chen G | SSRN
Aim: To analyze predictive value of HbA1c for adverse prognosis in COVID-19.
|
|
|
1/8/21
|
AbdelHamid S, Hamdy N, Maged A, et al | PROSPERO
|
|
|
1/8/21
|
Gofir A, Rochmah MA, Putera DD | PROSPERO
|
|
|
1/7/21
|
Nyasulu P, Jacques TL, Ayele B | PROSPERO
|
|
|
1/7/21
|
Siribaddana P, Hewapathirana R, Sahay S | PROSPERO
|
|
|
1/7/21
|
Annaloro C, Caruso R | PROSPERO
|
|
|
1/7/21
|
Mitra S, Ling RR, Tan CS, et al | PROSPERO
|
|
|
1/7/21
|
Vergara S HD | PROSPERO
|
|
|
1/7/21
|
Ming W, Chen J, Wang Y, et al | PROSPERO
|
|
|
1/7/21
|
Hosseini MS, Nikniaz L, Akbarzadeh MA, et al | PROSPERO
|
|
|
1/7/21
|
Bertini P, Landoni, Paternoster G | PROSPERO
|
|
|
1/6/21
|
Subali AD, Wiyono L | medRxiv
Aim: To examine RT-LAMP application for rapid identification of SARS-CoV-2 infection compared to RT-PCR assay.
|
|
|
1/5/21
|
de Freitas RF, Torres SC, Nunes JPL | medRxiv
Aim: To examine the current incidence of syncope in COVID-19 patients and to explore different patterns observed in this setting.
|
|
|
1/5/21
|
Nikniaz L, Akbarzadeh MA, Hosseinifard H, et al. | medRxiv
Aim: To evaluate the effects of vitamin D supplementation on clinical outcomes and mortality rate of COVID-19 patients.
|
|
|
1/4/21
|
Major A, Hlubocky FJ | medRxiv
Aim: To rapidly review recently-published literature on the mental health of HCWs during the COVID-19 pandemic.
|
|
|
1/4/21
|
Aberhe W, Mariye T, Hailay A, et al. | New Microbes New Infect
|
|
|
12/31/20
|
de Souza TA, de Almeida Medeiros A, Barbosa IR, et al. | Medicine
|
|
|
12/31/20
|
Chen Y, Zhang Q, Peng W, et al. | BMJ Open
|
|
|
12/31/20
|
Qiu G, Ji Y, Tan Y | Medicine
|
|
|
12/30/20
|
Sinha A, Nayak S, Dehuri P, et al. | BMJ Open
|
|
|
12/30/20
|
Sallam M | Preprints
Aim: To provide an up-to-date assessment of COVID-19 vaccination acceptance rates worldwide.
|
|
|
12/30/20
|
Li Z, Che Q, Li M, et al. | Research Square
Aim: To explore the effectiveness and safety of tocilizumab recently used for treating patients with COVID-19.
|
|
|
12/30/20
|
Zhang M, Huang J, Wu X, et al. | Medicine
|
|
|
12/30/20
|
Duarte G, Ortiz-Munoz L, Morales MB, et al | Medwave
|
|
|
12/29/20
|
Almeda N, Garcia-Alonso CR, Salvador-Carulla L | Research Square
Aim: To identify, describe and assess the empirical background on online strategies and recommendations developed by international organizations and governments to cope with the psychological impact of COVID-19.
|
|
|
12/29/20
|
Yu H, Zhou Z, Mo Q, et al. | Research Square
Aim: To evaluate the current evidence on the prevalence of depression and anxiety in cancer patients during the COVID-19 pandemic.
|
|
|
12/28/20
|
Daley C, Fydenkevez M, Ackerman-Morris S | medRxiv
Aim: To investigate the incubation period of COVID-19 with regard to age, biological sex, location, and severity of the disease.
|
|
|
12/28/20
|
Hoang T | medRxiv
Aim: To examine the characteristics of repositive COVID-19 cases.
|
|
|
12/28/20
|
Kim H, Hwang H, Hong H, et al. | Research Square
Aim: To review the differences in risk factors for critical outcomes of patients with COVID-19 according to the contintent on which the studies were performed.
|
|
|
12/24/20
|
Hayer J, Kasapic D, Zemmrich | medRxiv
Aim: To compare the real-world clinical performance of commercially available rapid chromatographic immunoassays intended for the qualitative detection of SARS-CoV-2.
|
|
|
12/23/20
|
Zhang C, Jin H, Wen Y, et al. | medRxiv
Aim: To provide a comprehensive evaluation of efficacy of available treatments for COVID-19.
|
|
|
12/23/20
|
Huang K | PROSPERO
|
|
|
12/23/20
|
Hayward SE, Deal A, Cheng C, et al. | medRxiv
Aim: To assess clinical outcomes of COVID-19 in migrant populations (cases, hospitalisations, deaths), indirect health and social impacts, and to determine key risk factors.
|
|
|
12/23/20
|
Xing W | PROSPERO
|
|
|
12/23/20
|
Gray L, Campbell J, Hobbs M, et al | PROSPERO
|
|
|
12/23/20
|
Boden M, Cohen N, Froelich J, et al. | medRxiv
Aim: To review the evidence on whether mental disorder prevalence: (a) was elevated among populations impacted by coronavirus pandemics (relative to unselected populations reported in the literature), and (b) varied by disorder (undistinguished psychiatric morbidity, anxiety, depressive, posttraumatic stress disorders [PTSD]) and impacted population (community, infected/recovered, healthcare provider, quarantined).
|
|
|
12/23/20
|
Penner K, Neitzel C | PROSPERO
|
|
|
12/23/20
|
Booth A, Reed AB, Ponzo S, et al. | medRxiv
Aim: To systematically map all the available evidence on the association of various clinical, demographic, and lifestyle variables with the risk of specific adverse outcomes in patients with COVID?19.
|
|
|
12/23/20
|
Li Z, Yin M, Xu T, et al | PROSPERO
|
|
|
12/23/20
|
Ma L, Lu H, Wu M, et al. | Research Square
Aim: To reveal the epidemiological characteristics and potential influencing factors of COVID-19 and provide reference for the prevention and treatment of patients.
|
|
|
12/22/20
|
Chi W, Chen Y, Wang L, et al. | Medicine
|
|
|
12/22/20
|
Mendes NF, Jara CP, Mansour E, et al. | Research Square
Aim: To review the evidence on the description of asthma as a premorbid condition and its putative association with severe progression of the disease.
|
|
|
12/22/20
|
Toloui A, Moshrefiaraghi D, Neishaboori AM, et al. | Research Square
Aim: To investigate the evidence regarding the prevalence of cardiac complications and the resulting mortality rate in COVID-19 patients.
|
|
|
12/22/20
|
Acuff S, Strickland J, Murphy J | PROSPERO
|
|
|
12/22/20
|
Kundal VK, Kundal R, Kant V, et al | PROSPERO
|
|
|
12/22/20
|
Wagner C, Fichtner F, Griesel M, et al | PROSPERO
|
|
|
12/22/20
|
Welte T, Ambrose LJ, Sibbring GC, et al. | medRxiv
Aim: To identify clinical trials of pharmacological interventions for COVID-19 and evaluate for effectiveness.
|
|
|
12/22/20
|
Maglalang D, Gali K, Prochaska J | PROSPERO
|
|
|
12/22/20
|
Prasad M, Seth T, Arunmozhimaran E | PROSPERO
|
|
|
12/22/20
|
Ma L, Song JN, Song YP, et al. | Medicine
|
|
|
12/22/20
|
Hull KL, Selvaskandan H, Cheung CK, et al | PROSPERO
|
|
|
12/22/20
|
Chauhan AS, Choudhry V, Khetrapal S, et al | PROSPERO
|
|
|
12/22/20
|
Palaiodimou L, Stefanou MI, Katsanos A, et al | PROSPERO
|
|
|
12/22/20
|
Almonte M, Bennet P, Perry A, et al | PROSPERO
|
|
|
12/22/20
|
Pimenta IDSF, de Sousa Mata ÁN, Braga LP, et al. | Medicine
|
|
|
12/22/20
|
Occurrence of cardiovascular complications associated with SARS-CoV-2 infection: a systematic review
Sardinha DM, Lima KVB, Ueno T, et al. | medRxiv
Aim: To investigate the occurrence of cardiovascular complications associated with SARS-CoV-2 infection.
|
|
|
12/22/20
|
Fragkoiu PC, Moschopoulos CD, Ong DSY, et al | PROSPERO
|
|
|
12/22/20
|
Li YK, Yang JZ, Li DD | PROSPERO
|
|
|
12/22/20
|
Zhong J, Si L, Xing Y, et al | PROSPERO
|
|
|
12/22/20
|
Calzetta L, Ritondo BL, Chetta A, et al | PROSPERO
|
|
|
12/22/20
|
Kaggwa MM, Najjuka SM | PROSPERO
|
|
|
12/22/20
|
Huda MN, Malo JS, Khan S, et al | PROSPERO
|
|
|
12/22/20
|
Ao G, Wang Y, Qi X | PROSPERO
|
|
|
12/22/20
|
Liu R, Mou R, Jin X, et al | Research Square
|
|
|
12/22/20
|
Zhang Y, Chen W | PROSPERO
|
|
|
12/22/20
|
Ribeiro W, Lelis R, Sestelo M | PROSPERO
|
|
|
12/22/20
|
Cosco TD, Best J, Bryden D, et al. | medRxiv
Aim: To quantify the association between frailty and COVID-19 in relation to mortality in hospitalised patients. UPDATED
|
|
|
12/21/20
|
dos Santos Marinho SE | PROSPERO
|
|
|
12/21/20
|
Wolde HF, Akalu TY, Baraky AG, et al | PROSPERO
|
|
|
12/21/20
|
de Castro Correa C, Martins AA, Taveira KVM, et al | PROSPERO
|
|
|
12/21/20
|
Vieira W, Santana L | PROSPERO
|
|
|
12/21/20
|
Frampton Geoff, Tikhonova I, Cooper K, et al | PROSPERO
|
|
|
12/21/20
|
Hu D, Zhang H, Sun B, et al | PROSPERO
|
|
|
12/21/20
|
Gabiatti D, Do Prado Martins V, Vieira LG, et al | PROSPERO
|
|
|
12/18/20
|
Wang Q, Yang L, Jin H, et al | PROSPERO
|
|
|
12/18/20
|
Sulochan GC, Khanal A, Vijay GC, et al. | PROSPERO
|
|
|
12/18/20
|
Lee S, Moss H, Punch P, et al. | PROSPERO
|
|
|
12/18/20
|
Theodoratou E, Xu W, Nzvere FP, et al. | PROSPERO
|
|
|
12/18/20
|
Chen Y, Xiang Z, Huang Z, et al. | PROSPERO
|
|
|
12/18/20
|
Mostafa-Hadeab G, Elhady H | PROSPERO
|
|
|
12/18/20
|
Mawalla W, Njiro B, Bwire G, et al. | PROSPERO
|
|
|
12/18/20
|
O'Donnell S, Karam IF, Ramil J, et al. | PROSPERO
|
|
|
12/18/20
|
Jefferson L, Bloor K, Golder S, et al. | PROSPERO
|
|
|
12/18/20
|
Thakur A, Lin HY, Desarkar P, et al. | PROSPERO
|
|
|
12/18/20
|
Chin IS, Galavotti S, Yip KP, et al. | medRxiv
Aim: To investigate the impact of cancer patients’ characteristics, cancer type and recent treatment history on the risk of death in cancer patients following SARS-CoV-2 infection.
|
|
|
12/18/20
|
Moraes B, Silva J, Xavier A, et al. | PROSPERO
|
|
|
12/18/20
|
Almufarrij I, Munro K | PROSPERO
|
|
|
12/18/20
|
Romano A, Lucchese A, Serpico R, et al. | PROSPERO
|
|
|
12/17/20
|
Litwinowicz K, Choroszy M, Wrobel A, et al. | PROSPERO
|
|
|
12/17/20
|
Hamam O, Goda A, Eldalal M, et al. | medRxiv
Aim: To build concrete evidence regarding the incidence of cardiac arrhythmia in patients with COVID-19.
|
|
|
12/17/20
|
Al-Amer R, Salamonson Y, Villarosa A, et al. | PROSPERO
|
|
|
12/17/20
|
Nimavat N, Singh S | PROSPERO
|
|
|
12/17/20
|
Rocha-Filho C, Nunes Pinto ACP, da Rocha AP, et al | medRxiv
|
|
|
12/17/20
|
Li Z | PROSPERO
|
|
|
12/17/20
|
Li J, Rong J, Yang D | PROSPERO
|
|
|
12/17/20
|
de Oliveira Silva AS, e Vasconcelos ACS, Pereira AM, et al. | PROSPERO
|
|
|
12/17/20
|
Lausi G, Mari E, Pizzo A, et al. | PROSPERO
|
|
|
12/17/20
|
Lucendo AJ, Maestre-Muniz MM, Arias A | PROSPERO
|
|
|
12/17/20
|
Tu Y, Iqbal JZ, Oleary TJ | medRxiv
Aim: To determine the sensitivity of SARS-CoV-2 detection by ID NOW in an ambulatory population presenting for initial diagnostic testing.
|
|
|
12/17/20
|
Maraolo AE, Cascella M, Crispo A, et al. | PROSPERO
|
|
|
12/16/20
|
Schumacher M, Pollock KM, Robbins AJ | PROSPERO
|
|
|
12/16/20
|
Troxel A, Petkova E, Antman E | PROSPERO
|
|
|
12/16/20
|
Zhang Z, Zhong H, Liu Y, et al. | Ann Transl Med
|
|
|
12/16/20
|
Liu J, Yang X, Zhu Y, et al | PROSPERO
|
|
|
12/16/20
|
de Oliveira IJ, de Brito PVM, Tavares LA, et al | PROSPERO
|
|
|
12/16/20
|
Mansory E, Srigunapalan S, Lazo-Langner A | PROSPERO
|
|
|
12/16/20
|
Welsh V, Corp N, Burton C, et al | PROSPERO
|
|
|
12/16/20
|
Zhang A, Liu J, Yuan K, et al | PROSPERO
|
|
|
12/16/20
|
Moya-Salazar J, Canari B, Contreras-Pulache H | PROSPERO
|
|
|
12/16/20
|
Abdel-Gawad M, Alboraie M, Abd-Elsalam S, et al | PROSPERO
|
|
|
12/16/20
|
Semple SAJ, Ferreira N | PROSPERO
|
|
|
12/16/20
|
Wang Y, Dai R, Lv X, et al | PROSPERO
|
|
|
12/16/20
|
Brummer LE, Katzenschlager S, Geaddert M, et al | PROSPERO
|
|
|
12/16/20
|
Antonini M, Hinwood M, Balogh Z, et al | PROSPERO
|
|
|
12/16/20
|
Chen X, Huang Z, Wang J, et al. | Research Square
Aim: To estimate the rate of asymptomatic COVID-19 infection from published studies, and compare this rate among different patient groups.
|
|
|
12/15/20
|
Smith S, McLaren D, Gardani M | PROSPERO
|
|
|
12/15/20
|
Patel B, Smalley K, Delaney B | PROSPERO
|
|
|
12/15/20
|
Perdew M, Rhodes R, Liu S | PROSPERO
|
|
|
12/15/20
|
Ng S, He HG | PROSPERO
|
|
|
12/15/20
|
Mavrovounis G, Mermiri M, Chalkias A, et al | PROSPERO
|
|
|
12/15/20
|
Nascimento R, Araujo N | PROSPERO
|
|
|
12/15/20
|
Breivik VF, Havarstein IR, Linde DS, et al | PROSPERO
|
|
|
12/15/20
|
Hintermeier M, Gencer H, Kajikhina K, et al. | medRxiv
Aim: To synthesise the evidence on risk of infection and transmission among migrants, refugees, asylum seekers and internally displaced populations, and the effect of lockdown measures on these populations. UPDATED
|
|
|
12/15/20
|
Wu L, Luo X, Zhang S, et al | PROSPERO
|
|
|
12/15/20
|
Su Z, Meyer K, Li Y, et al. | Research Square
|
|
|
12/15/20
|
Apoorva HM, Jayaram M | PROSPERO
|
|
|
12/14/20
|
Fernandes JF, Detoc M, Gagneux-Brunon A | PROSPERO
|
|
|
12/14/20
|
Lim ZJ, Subramaniam A, Reddy MP, et al | PROSPERO
|
|
|
12/14/20
|
Monti C, Capra D, Cressoni M, et al | PROSPERO
|
|
|
12/14/20
|
Cozzi A, Ali M, Cresonni M, et al | PROSPERO
|
|
|
12/14/20
|
Yuan Y, Kang S | PROSPERO
|
|
|
12/14/20
|
Suh YJ, Kim JY | PROSPERO
|
|
|
12/14/20
|
Vishal K, Senthil Kumaran D, Mohapatra S | PROSPERO
|
|
|
12/14/20
|
Wunsch K, Kienberger K, Niessner C, et al | PROSPERO
|
|
|
12/14/20
|
Karam M, Althuwaikh S, Alazemi M, et al. | medRxiv
Aim: To compare the performance of chest computed tomography (CT) scan versus reverse transcription polymerase chain reaction (RT-PCR) in the initial diagnostic assessment of coronavirus disease 2019 (COVID-19) patients.
|
|
|
12/14/20
|
Yadav AK, Ghosh S, Dubey S | medRxiv
Aim: To summarize and synthesize evidence from all available case series and case reports on re-positive COVID-19 tests.
|
|
|
12/14/20
|
Dhivagaran T, Abbas U, Butt FR, et al. | Research Square
|
|
|
12/14/20
|
Monti C, Zanardo M, Schiafinno S, et al | PROSPERO
|
|
|
12/14/20
|
Cozzi A, Magni V, Schiaffino I, et al | PROSPERO
|
|
|
12/14/20
|
Liu R, Chen J, Mou R, et al | PROSPERO
|
|
|
12/14/20
|
Galanis PA, Vraka I, Fragkou D, et al. | medRxiv
Aim: To estimate the intention of HCWs to accept COVID-19 vaccination and to find out related factors.
|
|
|
12/14/20
|
Wang L | PROSPERO
|
|
|
12/14/20
|
Aguirre-Duarte N, Ovretveit J, Kenealy T | medRxiv
|
|
|
12/14/20
|
Araujo M, Chapman E, Mercer R, et al | PROSPERO
|
|
|
12/14/20
|
Zou J, Zhang Z, Zheng L | PROSPERO
|
|
|
12/14/20
|
Mapahla L, Chinhenzva A, Chivese T, et al | PROSPERO
|
|
|
12/14/20
|
Reddy MP | PROSPERO
|
|
|
12/11/20
|
Chiba T, Tanemura N, Nishijima C, et al | PROSPERO
|
|
|
12/11/20
|
Young S, Mackey K, Maldonado E, et al | PROSPERO
|
|
|
12/11/20
|
Arienti C, Young V, Catellini G, et al | PROSPERO
|
|
|
12/11/20
|
Ashra F, Yunitri N, Kustanti CY | PROSPERO
|
|
|
12/11/20
|
Zou J, Zhang Z, Zheng L | PROSPERO
|
|
|
12/11/20
|
Bonaccio M, Costanzo S, Mignogna C, et al | PROSPERO
|
|
|
12/11/20
|
Octaviana DS, Imania HAN, Kurniawan RB, et al | PROSPERO
|
|
|
12/11/20
|
Dono F, Nucera B, Speranza R, et al | PROSPERO
|
|
|
12/11/20
|
Xie Z, Yang Z, Wang S, et al | PROSPERO
|
|
|
12/11/20
|
Setyarini IB, Ratna N, Mudjihartini N | PROSPERO
|
|
|
12/11/20
|
Idelji-Tehrani S | PROSPERO
|
|
|
12/10/20
|
Tubasi A, AbuAnzeh R, Tawileh HA, et al | PROSPERO
|
|
|
12/10/20
|
Michelen M, Manoharan L, Elkheir N, et al. | medRxiv
Aim: To understand the frequency, profile, and duration of persistent symptoms of COVID-19 and to update this understanding as new evidence emerges. UPDATED
|
|
|
12/10/20
|
Jin Y, Zhang Y | PROSPERO
|
|
|
12/10/20
|
FioreM, Alfieri A, Corrente A, et al | PROSPERO
|
|
|
12/10/20
|
Meads C, McGowan V, Lowther H | PROSPERO
|
|
|
12/10/20
|
Xiao Y, Hinrichs R, Johnson N, et al | PROSPERO
|
|
|
12/10/20
|
Luo Z, Chen Y, Wang L, et al. | Medicine
|
|
|
12/10/20
|
Jiaming F, Wu L, Ma Y, et al. | Medicine
|
|
|
12/10/20
|
Wu J, Pu L, Zhou H, et al. | Medicine
|
|
|
12/10/20
|
Naghibi D, Azami-Aghdash S, Ghojazadeh M | PROSPERO
|
|
|
12/9/20
|
Rocha KO, Zanuncio VV, Lima LM | PROSPERO
|
|
|
12/9/20
|
Dimala CA, Kadia BM, Donato A | PROSPERO
|
|
|
12/9/20
|
Gofir A, Ar Rochman M, Hakimi M, et al | PROSPERO
|
|
|
12/9/20
|
Rattka M, Imhof A, Baumhardt M | PROSPERO
|
|
|
12/9/20
|
Lahiri A, Shrivastava N | PROSPERO
|
|
|
12/9/20
|
AbuAnzeh R, Toubasi A, Alzoubi L, et al | PROSPERO
|
|
|
12/9/20
|
Abraham G, Gelana B, Yitbarek K, et al. | Research Square
|
|
|
12/9/20
|
Menezes N, Malone J, Lyons C, et al. | Research Square
|
|
|
12/9/20
|
Frasquilho D, Almeida S, Sousa B, et al | PROSPERO
|
|
|
12/9/20
|
Sajadi HS, Nikbakht MA, Hosseini SE, et al | PROSPERO
|
|
|
12/8/20
|
Ahmed MAA, Diarra NH, Gagnon MP, et al | PROSPERO
|
|
|
12/8/20
|
Tan X, Wichmann D | PROSPERO
|
|
|
12/8/20
|
Chowdhury AI, Rabbi MF, Rahman T, et al. | medRxiv
Aim: To review the evidence on the effects of overweight and obesity on COVID-19 disease severity.
|
|
|
12/8/20
|
Chilibeck P, Shaw K, Butcher S, et al | PROSPERO
|
|
|
12/8/20
|
Dorri M, Rastad H, MHM Bazargani | PROSPERO
|
|
|
12/8/20
|
Robinson R | PROSPERO
|
|
|
12/8/20
|
Zand S | PROSPERO
|
|
|
12/8/20
|
Medeiros CT, de Filippis Capasso IRV, Pereira Horta MA | PROSPERO
|
|
|
12/8/20
|
Laukhtina E | PROSPERO
|
|
|
12/8/20
|
Campbell P, Ali M, Mason H, et al | PROSPERO
|
|
|
12/8/20
|
| Oxford COVID-19 Evidence Service
|
|
|
12/8/20
|
The safety and efficacy of azithromycin in COVID-19 treatment: a systematic review and meta analysis
Glendari G, Natalia N, Mangkuliguna G | PROSPERO
|
|
|
12/8/20
|
Hu C, Liang M, Zhao D | PROSPERO
|
|
|
12/7/20
|
Yigezu A, Yitayal M, Mirkuzie A, et al. | Research Square
Aim: To review the economic evaluation of public health measures against COVID-19 and influenza pandemics.
|
|
|
12/7/20
|
Zhu Y, Xing W, Wang Hui, et al | PROSPERO
|
|
|
12/7/20
|
Yap M, Debenham L, Kew T, et al. | BMJ Open
|
|
|
12/7/20
|
De Armond M, Feliciano S, Hirabayashi E, et al | PROSPERO
|
|
|
12/7/20
|
Karakike E, Giamarellos-Bourboulis EJ, Kyprianou M, et al. | medRxiv
Aim: To review the evidence on the prevalence of viral sepsis in COVID-19 patients.
|
|
|
12/7/20
|
Yasrab M, Awan S, Kamal A, et al | PROSPERO
|
|
|
12/7/20
|
Lee KS, Siow I, Zhang J, et al | PROSPERO
|
|
|
12/7/20
|
Du X, Shi L, Cao W | PROSPERO
|
|
|
12/7/20
|
Lou B, Guo J, Liu Y, et al | PROSPERO
|
|
|
12/7/20
|
Donohoe-Bales A, Smout S, Bower M, et al | PROSPERO
|
|
|
12/7/20
|
Cammarota G, De Robertis E | PROSPERO
|
|
|
12/7/20
|
Daniels S, Wei H, Han Y, et al | PROSPERO
|
|
|
12/7/20
|
Degarege A, Naveed Z, Kabayundo J, et al. | medRxiv
Aim: To synthesize the evidence on the impact of demographics and comorbidities with clinical outcomes of COVID-19, including severe illness, admission to the intensive care unit (ICU), and death.
|
|
|
12/7/20
|
Al Sabouri AAK, Al Zoghbi A, Said N | PROSPERO
|
|
|
12/7/20
|
Singh M, Chauhan A, Jaiswal N, et al | PROSPERO
|
|
|
12/6/20
|
Hernried B, Levin S, Hinson J, et al | PROSPERO
|
|
|
12/4/20
|
Chen J, Tang R, Dong R, et al | PROSPERO
|
|
|
12/4/20
|
Meza N, Perez-Bracchiglione J, Perez I, et al. | OSF Preprints
|
|
|
12/4/20
|
Tieyjeh I, Kashour T, Almamlouk R, et al | PROSPERO
|
|
|
12/4/20
|
Subramanuam A, Brown H, Reddy MP, et al | PROSPERO
|
|
|
12/4/20
|
Tjahjadi AK, Anindyah G, Kaswandani N | PROSPERO
|
|
|
12/4/20
|
Nurcahyani, Multazam RB, Jane CM, et al | PROSPERO
|
|
|
12/4/20
|
Yap M, King Y, Zhou D, et al | PROSPERO
|
|
|
12/4/20
|
Das P, Samad N, Ahinkorah BO, et al. | medRxiv
Aim: To identify and synthesis available evidence to aid the understanding of the possible effect of vitamin D deficiency on COVID-19 status and health outcomes in COVID-19 patients.
|
|
|
12/4/20
|
Ayahrul S, Fajar JK, Harapan H, et al | PROSPERO
|
|
|
12/4/20
|
Al Zoghbi A, Ak-Khayat Sabouri A, Said N | PROSPERO
|
|
|
12/4/20
|
Whitehead C, Peart S, Manley B, et al | PROSPERO
|
|
|
12/4/20
|
Robinson E, Jones A, Lesser I, et al. | medRxiv
Aim: To address the current lack of consensus on; i) the proportion of the population willing to be vaccinated against COVID-19 when a vaccine become available and how this differs across countries, ii) whether vaccination intentions have declined as the pandemic has progressed, iii) socio-demographic inequalities in intended vaccine uptake. UPDATED
|
|
|
12/4/20
|
Boutron I, Chaimani A, Devane D, et al. | Cochrane Database Syst Rev
|
|
|
12/4/20
|
Meherali S | PROSPERO
|
|
|
12/4/20
|
Izcovich A, Ragusa M, Sanguine V, et al. | medRxiv
Aim: To identify prognostic factors that can potentially be used in decision-making related to the care of patients infected with COVID-19.
|
|
|
12/4/20
|
Pranata R, Henrina J, Huang I, et al | PROSPERO
|
|
|
12/4/20
|
Drame M | PROSPERO
|
|
|
12/4/20
|
Zhang Y, Yu S, Xu Y, et al. | medRxiv
Aim: To explore the impact of RAS inhibitor use on the risk of SARS-CoV-2 infection and the prognosis of SARS-CoV-2 infected patients, from all published studies.
|
|
|
12/4/20
|
Kazibwe J, Shah H, Guinness L | PROSPERO
|
|
|
12/4/20
|
Huaiyu X, Yalei W, Meng Z | PROSPERO
|
|
|
12/4/20
|
Perdana TM, Saktiawati A | PROSPERO
|
|
|
12/3/20
|
Maurya M, Konwar M, Bose D | PROSPERO
|
|
|
12/3/20
|
Iqbal F, Ashrafian H | PROSPERO
|
|
|
12/3/20
|
Nan J, Wan H, Zhao X, et al | PROSPERO
|
|
|
12/3/20
|
Castillo-Perez M, Ramonfaur D, Garcia-Pons JF, et al | PROSPERO
|
|
|
12/3/20
|
Charalambous C, Mastan S, Ahmed W, et al | PROSPERO
|
|
|
12/3/20
|
Nicolucci A, Maione A, Lucisano G, et al | PROSPERO
|
|
|
12/3/20
|
Harder T, Vygen-Bonnet S, Koch J, et al | PROSPERO
|
|
|
12/3/20
|
Chen P, Bobrovitz N, Premji Z, et al. | medRxiv
Aim: To review the evidence on transmissibility of SARS-CoV-2, including mechanistic correlates of overdispersion, viral kinetics, and infectiousness. UPDATED
|
|
|
12/3/20
|
Pratiwi C, Dahlan TF, Zulkifly S, et al | PROSPERO
|
|
|
12/3/20
|
Zhu S, Zhang W | PROSPERO
|
|
|
12/3/20
|
da Rocha Reis MB, Pimenta LC, Brito DA, et al | PROSPERO
|
|
|
12/3/20
|
Huang L, Li P, Zhap R, et al | PROSPERO
|
|
|
12/3/20
|
Giles-Vernick T, Yeoh EK, Matta G, et al | PROSPERO
|
|
|
12/3/20
|
Long Q, Cao F, Jiao Y | PROSPERO
|
|
|
12/3/20
|
Nan J, Peng J, Chen C, et al | PROSPERO
|
|
|
12/3/20
|
Cordy C, Sephry, TBA | PROSPERO
|
|
|
12/3/20
|
Wood S, Harrison S, Judd N, et al | PROSPERO
|
|
|
12/2/20
|
Vengesai A, Midzi H, Kasambala M, et al. | Research Square
Aim: To evaluate the diagnostic accuracy of IgG and IgM based point-of-care (POC) lateral flow immunoassay (LFIA), chemiluminescence enzyme immunoassay (CLIA), fluorescence enzyme-linked immunoassay (FIA) and ELISA systems that detect SARS-CoV-2 antigens. UPDATED
|
|
|
12/2/20
|
Sherrif RS, Ostinelli E, Shokraneh F, et al | PROSPERO
|
|
|
12/2/20
|
Tian Y, Wu Q, Li H, et al. | Research Square
Aim: To review the evidence on the clinical characteristics of COVID-19 in patients based on geographical regions. UPDATED
|
|
|
12/2/20
|
Chen C, Shao S, Chen Y, et al. | Research Square
Aim: To summarize current epidemiological evidence regarding COVID-19 infection in HD patients.
|
|
|
12/2/20
|
Auyeung A, Kumar R, Cripps R, et al | PROSPERO
|
|
|
12/1/20
|
Hayanga B, Becares L, Stafford M, et al | PROSPERO
|
|
|
12/1/20
|
Hidayati HB, Kenconowungu CD, Kurniawan RB, et al | PROSPERO
|
|
|
12/1/20
|
Lai SY, Hoffman B, Hoffman B, et al | PROSPERO
|
|
|
12/1/20
|
Allman J, Veenith T, Mehta R, et al | PROSPERO
|
|
|
12/1/20
|
Liu Y, Chen W, Zhou C | PROSPERO
|
|
|
12/1/20
|
Nugraha A, Utama TA, Dianty FE, et al | PROSPERO
|
|
|
12/1/20
|
Fiore M, La Verde M, Higgins Agnes, et al | PROSPERO
|
|
|
12/1/20
|
Barnett P, Goulding L, Casetta C, et al. | medRxiv
Aim: To conduct an umbrella review of systematic reviews of research literature and evidence-based guidance on remote working in mental health. UPDATED
|
|
|
12/1/20
|
Shemirani AH, Sadeghi F, Csiki Z, et al | PROSPERO
|
|
|
12/1/20
|
Devoe D, Patten S, Dimitropoulos G, et al | PROSPERO
|
|
|
11/30/20
|
Yan H, Engler K, Lebouche B | PROSPERO
|
|
|
11/30/20
|
Wu Q, Chen X, Yu H | PROSPERO
|
|
|
11/30/20
|
Jin Y, Wu L, Hong S, Jiang S, et al | PROSPERO
|
|
|
11/30/20
|
Pranata R, Lim M, Huang I, etal | PROSPERO
|
|
|
11/30/20
|
Asfaw L | PROSPERO
|
|
|
11/30/20
|
Rugg-Gunn C, Hawcutt D, Deakin M | PROSPERO
|
|
|
11/30/20
|
Sishuba-Zulu MD, Jaca A, Wiysonge S, et al | PROSPERO
|
|
|
11/30/20
|
Nicacio JM, Gomes OV | PROSPERO
|
|
|
11/30/20
|
Shao G, Huang S, Cui Y, et al. | Medicine
|
|
|
11/30/20
|
Li J, Yue J, Zhang S, et al. | Medicine
|
|
|
11/30/20
|
Du P, Zhou A, Du X, et al | PROSPERO
|
|
|
11/30/20
|
Ren X, Shi Y, Li G | Medicine
|
|
|
11/28/20
|
Chen D, Shang X, Ren XX, et al | PROSPERO
|
|
|
11/27/20
|
Kumar A, Kulandhasamy M, Prasoon P, et al. | SSRN
Aim: To consolidate the available knowledge of molecular mechanism(s) behind sex-based differences in viral infections.
|
|
|
11/27/20
|
Simsek B, Selte A, Cakatay U | PROSPERO
|
|
|
11/27/20
|
Wu T, Jia X, Shi H, et al | PROSPERO
|
|
|
11/27/20
|
Mutiawati E, Fahriani M, Fajar JK, et al | PROSPERO
|
|
|
11/27/20
|
Saragih ID, Saragih IS, Lin CJ, et al | PROSPERO
|
|
|
11/27/20
|
Komolafe TE, Nguchu BA, Sun H, et al | PROSPERO
|
|
|
11/27/20
|
Niu J, Chen H, Chen K, et al. | Medicine
|
|
|
11/27/20
|
Romli MH, Cheema MS, Mehat MZ, et al. | BMJ Open
|
|
|
11/27/20
|
Humphries K, Wolloughby, Clark C, et al | PROSPERO
|
|
|
11/27/20
|
Freiberg A, Drossler S, Horvath K, et al | PROSPERO
|
|
|
11/27/20
|
Branjerdporn G, Stapelberg C, Bowman C | PROSPERO
|
|
|
11/27/20
|
Galanis P, Vraka I, Fragkou D, et al. | medRxiv
Aim: To examine the impact of the COVID-19 pandemic on nurses’ burnout and to identify associated risk factors.
|
|
|
11/27/20
|
Jin W, Song Y, Lu Y, et al | PROSPERO
|
|
|
11/27/20
|
Sheerin D, Abhimanyu A, Wang X, et al. | medRxiv
Aim: To understand the interaction between these diseases by profiling COVID-19 gene expression signatures on RNA-sequencing data from TB-infected individuals.
|
|
|
11/27/20
|
Hajihoseini M, Jalilo MR, Haghighatmanesh E | PROSPERO
|
|
|
11/27/20
|
Jolliffe D, Camargo C, Sluyter J, et al. | medRxiv
Aim: To determine whether vitamin D reduced ARI risk overall, and to evaluate whether effects of vitamin D on ARI risk varied according to baseline 25(OH)D concentration and/or dosing regimen (frequency, dose size, and trial duration).
|
|
|
11/26/20
|
Addo I, Asare B, Mensah E, et al | PROSPERO
|
|
|
11/26/20
|
Li X, Liu Y, Pan Y, et al | PROSPERO
|
|
|
11/26/20
|
Mao Y, Wang CT, Zhao Y | PROSPERO
|
|
|
11/26/20
|
Pranata R, Yonas E, Huang I, et al | PROSPERO
|
|
|
11/26/20
|
Yang Y, Shen Y, Zhang M | PROSPERO
|
|
|
11/26/20
|
Ceban F, Nogo D, Nasri F, et al | PROSPERO
|
|
|
11/26/20
|
Cardot T, Jossare L, Herr M, et al | PROSPERO
|
|
|
11/26/20
|
Choi WS, Kim NS, Choi J | PROSPERO
|
|
|
11/26/20
|
Andersson O, Rabe H, Mercer J, et al | PROSPERO
|
|
|
11/26/20
|
Whittaker E, Patel H, Scholefield B, | PROSPERO
|
|
|
11/25/20
|
Clark A, Botham J, McCrone P, et al | PROSPERO
|
|
|
11/25/20
|
Zhang N, Yun R, Liu L, et al. | Medicine
|
|
|
11/25/20
|
Grepin KA, Ho T, Liu Z, et al. | medRxiv
Aim: To review evidence of the effectiveness of travel measures implemented during the early stages of the COVID-19 pandemic in order to recommend change on how evidence is incorporated in the International Health Regulations (2005) (IHR).
|
|
|
11/25/20
|
Zhang X, Jiao J, Cao J, et al. | Research Square
Aim: To review the evidence on the association between frailty and mortality among COVID-19 patients.
|
|
|
11/25/20
|
Jolliffe D, Camargo CA, Sluyter J, et al. | medRxiv
Aim: To assess the overall effect of vitamin D supplementation on risk of acute respiratory infection (ARI), and to identify factors modifying this effect.
|
|
|
11/24/20
|
Sunjaya AP, Allida S, Di Tanna GL, et al | PROSPERO
|
|
|
11/24/20
|
Wing Ow ZG, Yi Teo VX, Yang Heng RR | PROSPERO
|
|
|
11/24/20
|
Jin G, Zhenghao X, Jia Z | PROSPERO
|
|
|
11/24/20
|
Slamang W, Abdullahi L, Mustafa F, et al | PROSPERO
|
|
|
11/24/20
|
Chen YT, Shao SC | PROSPERO
|
|
|
11/24/20
|
Marques JS, de Oliveura Meneses M, Gomes AT, et al | PROSPERO
|
|
|
11/24/20
|
Zhang N, Yun R, Liu L | Medicine
|
|
|
11/24/20
|
Nirmalasari PI, Indriasari R, Salam A | PROSPERO
|
|
|
11/24/20
|
Lu C, Lu T, Pan B, et al. | Ann Palliat Med
|
|
|
11/24/20
|
Wang Y, Huang Q, Zhang C | PROSPERO
|
|
|
11/24/20
|
Ma J, Wang R, Zheng Z, et al | PROSPERO
|
|
|
11/24/20
|
Papotsi E, Giannakoulis VG, Xourgia E, et al | PROSPERO
|
|
|
11/24/20
|
Freiberg A, Schubert M, Starke KR, et al | PROSPERO
|
|
|
11/24/20
|
Al-Moraissi EA, Abood M, Alasseri N, et al. | medRxiv
Aim: To assess the effectiveness of surgical mask vs respirators for protecting dental health care workers during dental and OMF AGPs surgical procedures. UPDATED
|
|
|
11/24/20
|
Ipekci MA, Buitrago-Garcia D, Meili KW, et al. | medRxiv
Aim: To compare the patterns of scientific publications for SARS-CoV-2 and Zika infections over time.
|
|
|
11/24/20
|
Emile S, Khan S, Hamid H | PROSPERO
|
|
|
11/24/20
|
Syed A, Albury C, Mat Lazim NH, et al | PROSPERO
|
|
|
11/24/20
|
Wang Y, Luo G, Chen X, et al. | Medicine
|
|
|
11/24/20
|
Chuchu Z, Meng Z, Yalei W | PROSPERO
|
|
|
11/24/20
|
Ford P, Potdar N | PROSPERO
|
|
|
11/24/20
|
Li J, Feng L, Zhao H, et al. | Research Square
|
|
|
11/24/20
|
Korang SK, Juul S, Nielsen EE, et al | Syst Rev
|
|
|
11/24/20
|
Mao G, Fernandes-Jesus M, Ntontis E, et al. | medRxiv
Aim: To review the evidence on the impact of COVID-19 volunteering both at the UK national level and the more local community level?
|
|
|
11/23/20
|
Zhang N, Yun RY, Liu L, et al. | Medicine
|
|
|
11/23/20
|
Latulippe K, LeBlanc A, Gagnon MP, et al | PROSPERO
|
|
|
11/23/20
|
Thomas M, Hull J, Song WJ, et al | PROSPERO
|
|
|
11/23/20
|
O'Leary T, Zhao Y | PROSPERO
|
|
|
11/23/20
|
Koutalos A, Ntalouka M, Malizos K, et al | PROSPERO
|
|
|
11/20/20
|
Kyriazopoulou E, Giamarellos-Bourboulis E, Kyprianou M, et al | PROSPERO
|
|
|
11/20/20
|
Olumade TJ & Uzairue LI | medRxiv
Aim: To conduct a meta-analysis of the clinical characteristics of COVID-19 patients in Africa.
CLINICAL CHARACTERISTICS
|
|
|
11/20/20
|
Dambha-Miller H, Albasri A, Hodgson S, et al. | BJGP Open
CANDIDATE THERAPEUTICS
|
|
|
11/20/20
|
Ayorinde A, Ghosh I, Zahair I, et al | PROSPERO
|
|
|
11/20/20
|
Evans C, Holmes K, Kazmierczak K | PROSPERO
|
|
|
11/20/20
|
Chen J, Xie L, Yuan P, et al. | medRxiv
Aim: To determine whether serum vitamin D is independently associated with COVID-19 infection and outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/20/20
|
Ganesh A, Randall M | PROSPERO
|
|
|
11/20/20
|
Meng Z, Yalei W, Chuchu Z | PROSPERO
|
|
|
11/20/20
|
Dellafiore F, Nania T, Barello S | PROSPERO
|
|
|
11/20/20
|
Cherak S, Fiest K, Krewulak K, et al | PROSPERO
|
|
|
11/20/20
|
Kawaguchi A, Levy M, Jouvet P | PROSPERO
|
|
|
11/20/20
|
Yunitri N | PROSPERO
|
|
|
11/20/20
|
Somagutta MR, Pormento MKL, Hamid P, et al. | Research Square
Aim: To assess anakinra's safety and efficacy for treating severe coronavirus disease in 2019 (COVID-19). UPDATED
|
|
|
11/20/20
|
Barochiner J & Martinez R | medRxiv
Aim: To determine a possible association between the use of ACEI/ARB and the progression of COVID-19 to severe forms or death.
|
|
|
11/20/20
|
Bussink-Voorend D, Hulscher M, Huatvast J, et al | PROSPERO
|
|
|
11/20/20
|
Koh J, Urbish SS, Pang VJ, et al | PROSPERO
|
|
|
11/19/20
|
Xu J, Ma XP, Bai L, et al. | Medicine
Aim: To assess if the effect estimate of any intervention improves the outcomes and safety profile for Severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2).
CLINICAL CHARACTERISTICS
|
|
|
11/19/20
|
Izcovich A, Siemieniuk R, Bartoszko JJ, et al. | medRxiv
Aim: To provide a summary of the evidence for all drugs used in the treatment of COVID-19.
|
|
|
11/19/20
|
Islam MS, Barek MA, Aziz MA, et al. | medRxiv
Aim: To evaluate risk factors, the prevalence of comorbidity, and clinical characteristics in COVID-19 death patients compared to survival patients that can be used as a reference for further research and clinical decisions.
|
|
|
11/19/20
|
Meng Y, Wang J, Wen K, et al. | Research Square
Aim: To present systematic reviews and detailed estimates of the major symptoms of COVID-19, determine the prevalence of serious comorbidities, and assess patient progression via comorbidities, major symptoms and laboratory examination to help severe patients and effectively reduce the mortality of COVID-19 under the condition of limited medical resources.
|
|
|
11/19/20
|
Li Y, He W | medRxiv
Aim: To review the evidence on the efficacy and safety of different COVID-19 drugs.
|
|
|
11/19/20
|
Keikha M, Karbalaei M | Research Square
Aim: To review the evidence on the effects of CP on clinical improvement, increase of discharged cases, as well as reducing mortality of infected patients by viruses SARS-CoV-1, MERS-CoV, and SARS-CoV-2.
|
|
|
11/19/20
|
Marra LP, Matuoka JY, de Oliveira Junior HA | PROSPERO
|
|
|
11/19/20
|
Evidence of the effectiveness of drug treatments for COVID-19: a systematic review and meta-analysis
Barbosa Santana MP, Silva BO, Alves PM | PROSPERO
|
|
|
11/19/20
|
Bobrovitz N, Arora R, Cao C, et al. | medRxiv
Aim: To synthesize seroprevalence data to better estimate the burden of SARS-CoV-2 infection, identify high-risk groups, and inform public health decision making. UPDATED
|
|
|
11/19/20
|
Espino P, Quincho-Lopez D, Quincho-Lopez A, et al | PROSPERO
|
|
|
11/19/20
|
Ferreira Gurgel MV, de Oliveira Gaudencio | PROSPERO
|
|
|
11/19/20
|
Zhao Y, Yin L | PROSPERO
|
|
|
11/19/20
|
Born J, Beymer D, Rajan D, et al. | medRxiv
Aim: To review the evidence on medical imaging in COVID-19 and the utility of AI.
|
|
|
11/19/20
|
Jimenez-Mora MA, Varela AR, Meneses-Echavez JF, et al. | Research Square
|
|
|
11/19/20
|
Meybohm P, Kranke P, Schmid B, et al | PROSPERO
|
|
|
11/19/20
|
Chambergo-Michilot D, Torres-Gomez | PROSPERO
|
|
|
11/19/20
|
Ackah M | PROSPERO
|
|
|
11/18/20
|
Banerjee T, Sharma S, Singh A | PROSPERO
|
|
|
11/18/20
|
AbdelMassih A, Menshawey R, Hozaien R, et al. | Research Square
Aim: To suggest that exercise is an important adjuvant strategy for prevention of re-infection and for development of better protective responses following vaccination.
|
|
|
11/18/20
|
Verjel C, Delgado O, Arango D, et al | PROSPERO
|
|
|
11/18/20
|
Vasconcelos AC, Schuch L, Ferreira L, et al | PROSPERO
|
|
|
11/18/20
|
Yalei W, Huaiyu X | PROSPERO
|
|
|
11/18/20
|
Zhu Y, Wang F | Research Square
|
|
|
11/18/20
|
Zhang L, Yan M, Takashima K, et al. | JMIR Res Protoc
|
|
|
11/18/20
|
Whiteman E | medRxiv
Aim: To investigate the association between hypertension as an existing comorbidity and mortality in hospitalized patients with confirmed coronavirus disease 2019 (COVID-19)
|
|
|
11/18/20
|
Davies K, Krogh C | PROSPERO
|
|
|
11/17/20
|
Hamam O, Goda A, Awad R, et al. | medRxiv
Aim: To build concrete evidence regarding the incidence and mortality of pulmonary embolism (PE) in patients with COVID-19.
|
|
|
11/17/20
|
Raheman F, Rojoa D, Parekh J, et al | PROSPERO
|
|
|
11/16/20
|
Wang Z, Zhang J, Du D, et al. | Medicine
|
|
|
11/16/20
|
Deng G, Zeng F, Deng Y, et al | PROSPERO
|
|
|
11/16/20
|
Wu S, Zhou Q, Zeng X, et al. | Research Square
Aim: To evaluate comparative efficacy and safety of pharmacological interventions in patients with coronavirus disease 2019. UPDATED
|
|
|
11/16/20
|
Zhou H, Chen D, Zhang Y, et al. | Medicine
|
|
|
11/16/20
|
Prabhu P, Parmar A | PROSPERO
|
|
|
11/16/20
|
Egglestone R, Pappachan JV, Cumpstey AF, et al | PROSPERO
|
|
|
11/16/20
|
Chambergo-Michilot D, Barros-Sevillano S, Rivera-Torrejon O | PROSPERO
|
|
|
11/16/20
|
Russo G, Jesus TS, Deane K, et al | PROSPERO
|
|
|
11/16/20
|
Longchamp G, Manzocchi-Besson S, Longchamp A, et al. | Research Square
Aim: To systematically review and meta-analyze the risk of clinically relevant VTE in patients hospitalized for COVID-19. UPDATED
|
|
|
11/16/20
|
Nasrullah SM, Tasnim Z, Hasan | PROSPERO
|
|
|
11/16/20
|
Arcadepani F, Fidalgo T | PROSPERO
|
|
|
11/16/20
|
Ollila H, Laine L, Koskela J | PROSPERO
|
|
|
11/16/20
|
de Souza TA, de Almeida Medeiros A, da Silva Nunes AD, et al | Medicine
|
|
|
11/16/20
|
Wang Y, Han L, Zhang W, et al. | Medicine
|
|
|
11/16/20
|
Liu Y, Fan X, Wang K, et al | PROSPERO
|
|
|
11/16/20
|
Kim YJ, Qian L, Aslam MS, et al. | Medicine
|
|
|
11/16/20
|
Pan D, Sze S, Khunti K, et al | PROSPERO
|
|
|
11/14/20
|
Yao J, Chen L, Wang K, et al | PROSPERO
|
|
|
11/13/20
|
Rothe M, Rohm E, Mitchell E, et al. | medRxiv
Aim: To review the evidence on hygiene intervention effectiveness against SARS-CoV-2.
|
|
|
11/13/20
|
Katzenschlager S, Zimmer AJ, Gottschalk C, et al. | medRxiv
Aim: To assess demographic, laboratory and clinical indicators as predictors for severe courses of COVID-19. UPDATED
|
|
|
11/13/20
|
Guerrero JI, Barragan LA, Martinez JD, et al. | Research Square
Aim: To describe the features of the central and peripheral nervous system involvement by COVID-19 in terms of pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. UPDATED
|
|
|
11/13/20
|
Chen H, Shi J, Shi W, et al. | BMJ Open
|
|
|
11/13/20
|
Crowe L, Anderson V, Pugh R | PROSPERO
|
|
|
11/13/20
|
Vogt F | PROSPERO
|
|
|
11/13/20
|
Mocellin MC, Curioni C, da Silva Pereira A, et al | PROSPERO
|
|
|
11/13/20
|
Lim ZJ, Reddy MP, Shekar K, et al | PROSPERO
|
|
|
11/13/20
|
Alenezi F, Almeshari M, Olayan L, et al | PROSPERO
|
|
|
11/12/20
|
Bailey A, Allan D | PROSPERO
|
|
|
11/12/20
|
Chen CH, Lai CC, Wang CY | PROSPERO
|
|
|
11/12/20
|
Boonyawat K, Chantrathammachart P, Namthaveg P, et al. | Research Square
Aim: to explore the incidence of venous and arterial thromboembolism among COVID-19 patients requiring hospitalization.
|
|
|
11/12/20
|
Afroz A, Biliah B, Naher Siddiquea B, Narendra Shetty A, et al | PROSPERO
|
|
|
11/12/20
|
Rittiphairoj T, Saringkarisate K, Kaewkamjonchai P, et al | PROSPERO
|
|
|
11/12/20
|
dos Santos Cordeiro G, Da Aninciacao do Espirito Santo D, | PROSPERO
|
|
|
11/12/20
|
Smith ER, He S, Oakley E, et al. | medRxiv
|
|
|
11/12/20
|
Nasrullah SM, Tsnim Z, Hasan MK, et al | PROSPERO
|
|
|
11/12/20
|
Gallus S, Lugo A, Clancy L, et al | PROSPERO
|
|
|
11/12/20
|
Puzanian H, Ghezzawi M, El-Habar R, et al | PROSPERO
|
|
|
11/11/20
|
Parker J, Lyness E, Dambha-Miller H, et al | PROSPERO
|
|
|
11/11/20
|
Zhou C, An T, Liu Y, et al | PROSPERO
|
|
|
11/11/20
|
Mbakaya B, Chisale M, Kumwenda P, et al | PROSPERO
|
|
|
11/11/20
|
Soakaew S, Kanchanasurakit S, Kositamongkol C, et al | PROSPERO
|
|
|
11/11/20
|
Bates L, Riley S, Stoner L, et al | PROSPERO
|
|
|
11/11/20
|
Zheng YB, Yuan K, Sun YK, et al | PROSPERO
|
|
|
11/11/20
|
Qiu G, Qiu F, Chen D, et al | PROSPERO
|
|
|
11/11/20
|
Suk JE, Vardavas C, Nikitara K, et al. | medRxiv
Aim: To assess child-to-child and child-to-adult SARS-CoV-2 transmission and to characterise the potential role of school closures on community transmission.
|
|
|
11/10/20
|
Pereira Linhares FM, Correia de Abreu WJ, de Oliveira Cabral Melo, et al | PROSPERO
|
|
|
11/10/20
|
Tomfohr-Madsen L, Silang K, Sohal P | PROSPERO
|
|
|
11/10/20
|
Durao C, Henriques HR, Costa A, et al | PROSPERO
|
|
|
11/10/20
|
Chinnadurai R, Jeyalan V, Ponnusamy A, et al | PROSPERO
|
|
|
11/10/20
|
Daniels NF, Burrin C, Chang T, et al | PROSPERO
|
|
|
11/10/20
|
Lee B, Boyd L, Ling M, et al | PROSPERO
|
|
|
11/10/20
|
Avni T, Yahav D, Leibovici L | PROSPERO
|
|
|
11/10/20
|
Domne FM, De Lucca Da Silva J, de Alcantara Bonfirm J, et al | PROSPERO
|
|
|
11/9/20
|
Ngo BT, Marik P, Kory P, et al. | medRxiv
Aim: To determine the potential time course for development of treatments and vaccines, focusing on availability now and continuing in the last half of 2020.
|
|
|
11/9/20
|
Chen CH, Wang CY, Lai CC, et al | PROSPERO
|
|
|
11/9/20
|
Yu Z, Wang P, Chen B, et al | Medicine
|
|
|
11/9/20
|
Cao Y, Shan J, Gong Z, et al. | PLoS One
|
|
|
11/9/20
|
Alkofide H, Almohaizeie A, Alkharfy K, et al | PROSPERO
|
|
|
11/9/20
|
Bai H, Ji Y, Wang J, et al | Medicine
|
|
|
11/9/20
|
Kollikonda S, Karnati S, Chavan M | PROSPERO
|
|
|
11/9/20
|
Graham W, Calvert C, John J | PROSPERO
|
|
|
11/9/20
|
Li GF, Yu G, An XX, et al | PROSPERO
|
|
|
11/9/20
|
Saragih ID | PROSPERO
|
|
|
11/9/20
|
Cordeiro LP, Linhares E, Nogueira FGO, et al. | Research Square
Aim: To review the articles available about the use of GC in patients with COVID-19 and to provide a safer analysis of the effectiveness and recommendations for its use.
|
|
|
11/9/20
|
Shi J, Gao Y, Zhao L, et al. | Syst Rev
CLINICAL CHARACTERISTICS
|
|
|
11/9/20
|
Labrague LJ | medRxiv
Aim: To appraise and synthesize studies examining psychological resilience, coping behaviours, and social support among healthcare workers (HWCs) during the coronavirus pandemic.
|
|
|
11/9/20
|
Cavalcante T | PROSPERO
|
|
|
11/9/20
|
Amimo F, Lambert B, Magit A, et al. | Research Square
Aim: To review the current evidence on the impact of COVID-19 on HIV, tuberculosis, and malaria across Africa.
|
|
|
11/9/20
|
Helps S, LeCoyte M | PROSPERO
|
|
|
11/9/20
|
Duan Y, Ziong M, Wang H, et al. | Medicine
|
|
|
11/9/20
|
Wang Q, Li M, Zhu H, et al | PROSPERO
|
|
|
11/6/20
|
Cantu Alejo DR, Angeles Mar HJ, Arciniega Trevino AM, et al | PROSPERO
|
|
|
11/6/20
|
Zahiri J, Afsharinia MH, Hekmati Z, et al. | medRxiv
Aim: To review the most frequently reported imaging features in COVID-19 patients in order to provide a reliable insight into expected CT imaging manifestations in patients with positive reverse-transcription polymerase chain reaction (RT-PCR) test results, and also for the initial detection of patients with suspicious clinical presentation whose RT-PCR test results are false negative.
|
|
|
11/6/20
|
Messina A | PROSPERO
|
|
|
11/6/20
|
Schmeckenbecher J, Rattner K, Kapusta N | PROSPERO
|
|
|
11/6/20
|
Torres-Sanchez I, Perez-Gisbert L | PROSPERO
|
|
|
11/6/20
|
Coyle C, Buggy S, Cagney O, et al. | HRB Open Res
|
|
|
11/6/20
|
Meybohm P, Kranke P, Popp M, et al | PROSPERO
|
|
|
11/6/20
|
Alshammary, Alsughayyir J | PROSPERO
|
|
|
11/6/20
|
Othman F, Ismaeil T | PROSPERO
|
|
|
11/6/20
|
Mathioudakis AG, Alimani GS, Papadopoulos NG | PROSPERO
|
|
|
11/6/20
|
Javidnia J, Khojasteh S, Hosseini SA, et al | PROSPERO
|
|
|
11/6/20
|
Vijayan R, Sheikh M, Zaidi M, et al | PROSPERO
|
|
|
11/6/20
|
Dal Curtivo dos Passos J, Borges YS, Guiloski IC | PROSPERO
|
|
|
11/6/20
|
Blasco-Belled A, Gallardo CT, Alsinet C, et al | PROSPERO
|
|
|
11/5/20
|
Vaselli M, Shenton B, Hungerford D, et al | PROSPERO
|
|
|
11/5/20
|
Hunter J, Arentz S, Goldenberg J, et al. | medRxiv
Aim: To evaluate the benefits and risks of any type of zinc intervention to prevent or treat SARS-CoV-2.
|
|
|
11/5/20
|
Kirkland P, Russell M | PROSPERO
|
|
|
11/5/20
|
Chieng WK, Chong Lau DS, Tan CE, et al | PROSPERO
|
|
|
11/5/20
|
Thakur B, Dubey P, Benitez J, et al | PROSPERO
|
|
|
11/5/20
|
Santos R, Rego S, Brito L | PROSPERO
|
|
|
11/5/20
|
Graf E, Goetz T, Voracek M | PROSPERO
|
|
|
11/5/20
|
Safety, Tolerability, and Immunogenicity of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
Yuan P, Ai P, Liu Y, et al. | medRxiv
Aim: To summarize reliable medical evidence by the meta-analysis of all published clinical trials that investigated the safety, tolerability, and immunogenicity of vaccine candidates against coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
|
|
|
11/5/20
|
Zhu X, Liu C, Chen Y, et al | PROSPERO
|
|
|
11/5/20
|
Wang G, Hong X, Li J, Zhao M, et al | PROSPERO
|
|
|
11/5/20
|
Kallapur AS, Yen EY, Singh RR | medRxiv
Aim: To determine the prevalence of antiphospholipid (aPL), including lupus anticoagulant, anti-cardiolipin and anti-?2-glycoprotein-1 antibodies, and its possible association with thrombotic manifestations of COVID-19.
|
|
|
11/5/20
|
Kalin A, Greenhalgh T, Javid B, et al. | medRxiv
|
|
|
11/4/20
|
Frazer K, Mitchell L, Stokes D, et al | medRxiv
Aim: To investigate measures implemented in long term care facilities to reduce transmission of COVID-19 and their effect on morbidity and mortality of residents, staff, and visitors. UPDATED
|
|
|
11/4/20
|
Shebab M, Alrashed F, Shuaibi S, et al. | medRxiv
Aim: To evaluate the prevalence of GI, liver function test (LFT) abnormalities, and mortality of COVID-19 patients.
|
|
|
11/4/20
|
Di Castelnuovo A, Costanzo S, Cassone A, et al. | medRxiv
Aim: To evaluate the association between HCQ (with or without azithromycin (AZM)) and total mortality in COVID-19 patients.
|
|
|
11/4/20
|
Teixeira JRB, Barreto NMOV, Araujo WAC, et al | PROSPERO
|
|
|
11/3/20
|
Boutron I, Chaimani A, Devane D, et al. | Cochrane Database Syst Rev
|
|
|
11/3/20
|
Reddy MP, Subramaniam A, Lim ZJ, et al | medRxiv
Aim: To evaluate the impact of prone positioning on oxygenation and clinical outcomes. UPDATED
|
|
|
11/2/20
|
Zhang Y, Ma P, Zhang X, et al. | Medicine
|
|
|
11/2/20
|
Dhada S, Hadi MH, Cheema E, et al | PROSPERO
|
|
|
11/2/20
|
Demartini K, Alt L, Secchi J, et al | PROSPERO
|
|
|
11/2/20
|
Hung KC, Sun CK, Chiang MH | PROSPERO
|
|
|
11/2/20
|
Reddy S, Satani N, Beauchamp J, et al | PROSPERO
|
|
|
11/2/20
|
Zhang Y, Han H, Tian Y, et al. | Medicine
|
|
|
11/2/20
|
Huntley C, Mughal A, Patel K, et al | PROSPERO
|
|
|
11/2/20
|
Mou R, Jin X, Li W, et al. | Medicine
|
|
|
11/2/20
|
Cao C, Zhen Z, Kuang S, et al. | Medicine
|
|
|
11/2/20
|
Chen YJ, Deb A, Yang C, et al | PROSPERO
|
|
|
11/2/20
|
Montalto C, Pagnesi M, Lupi L, et al | PROSPERO
|
|
|
11/2/20
|
Asgarian-Omran H, Rajabinejad M | PROSPERO
|
|
|
11/2/20
|
Chen D, Zhou H, Yang Y, et al. | Medicine
|
|
|
11/2/20
|
Yang Y, Chen XFD, Chen Y, et al. | Medicine
|
|
|
11/2/20
|
Alwan NA, Davis H, Woodrow M, et al | PROSPERO
|
|
|
11/2/20
|
O'Donnell E, Haberli J, Dang K, et al | PROSPERO
|
|
|
10/30/20
|
Shi B, Li X, Luo J | PROSPERO
|
|
|
10/30/20
|
Khattab EM, Tam DNG, Aryal V, et al | PROSPERO
|
|
|
10/30/20
|
Mahamat-Saleh Y, Fiolet T, Aune D | PROSPERO
|
|
|
10/30/20
|
Speed T, Letzen J, Mun CJ, et al | PROSPERO
|
|
|
10/30/20
|
Li GF, Yu G, An XX, et al | PROSPERO
|
|
|
10/30/20
|
Bertini P, Paternoster G | PROSPERO
|
|
|
10/30/20
|
Chen X, Chen Z, Azman AS, et al. | medRxiv
Aim: To evaluate the quality of serological studies and provide a global picture of seroprevalence across demographic and occupational groups, and to provide guidance for conducting better serosurveys.
|
|
|
10/30/20
|
Zheng L, Huang Q, Yu N, et al | PROSPERO
|
|
|
10/30/20
|
Flannery F, Sheerin F, McCausland D, et al | PROSPERO
|
|
|
10/30/20
|
Mangkulinguna G, Glendari G, Natalia N, et al | PROSPERO
|
|
|
10/29/20
|
Gordon A, Sharpe J, Allen K, et al | PROSPERO
|
|
|
10/29/20
|
Pranata R, Lim M, Yonas E, et al | PROSPERO
|
|
|
10/29/20
|
So M, Copeland A, Zai C, et al | PROSPERO
|
|
|
10/29/20
|
Wells V, Pari A, Kuhn I, et al | PROSPERO
|
|
|
10/29/20
|
Saikia P, Thakuria B, Thottan R | PROSPERO
|
|
|
10/29/20
|
Kumar A, Kumari C, Narayan RK, et al | PROSPERO
|
|
|
10/29/20
|
Garbern S, Bills C, O'Reilly G, et al | PROSPERO
|
|
|
10/29/20
|
Ghosn L, Davidson M, Boutron I | PROSPERO
|
|
|
10/29/20
|
Moynihan R, Sanders S, Michaleff Z, et al | medRxiv
Aim: To determine the extent and nature of changes in utilisation of healthcare services during COVID-19 pandemic. UPDATED
|
|
|
10/29/20
|
Musuuza J, Watson L, Parmasad V, et al. | medRxiv
Aim: To examine occurrence of respiratory co-infections and superinfections and their outcomes among patients with SARS-CoV-2 infection. UPDATED
|
|
|
10/29/20
|
Emami A, Javanmardi F | PROSPERO
|
|
|
10/29/20
|
Khoo JY, Constantiou A, Yang C | PROSPERO
|
|
|
10/29/20
|
Mebrahtom G, Hailay A, Aberhe W, et al | PROSPERO
|
|
|
10/29/20
|
Rocha-Filho C, Nunes Pinto ACP, da Rocha AP, et al | PROSPERO
|
|
|
10/29/20
|
Pranata R, Henrina J, Lim M, et al | PROSPERO
|
|
|
10/28/20
|
Sharma P, Mahajan A, Rane S, et al. | SSRN
Aim: Not provided
|
|
|
10/28/20
|
Khera D, Chugh A, Khasbage S, et al. | Research Square
Aim: To review the evidence on the correlation between BCG vaccination and COVID-19 cases. UPDATED
|
|
|
10/28/20
|
Okoli G, Rabbani R, Copstein L, et al | PROSPERO
|
|
|
10/28/20
|
Seong D, Shin J, Kim MS | PROSPERO
|
|
|
10/28/20
|
Liang W, Shang B, Peiris, et al | PROSPERO
|
|
|
10/28/20
|
Bhagavathula AS, Rahmani J | PROSPERO
|
|
|
10/28/20
|
Baxter S, Blank L, Chambers D, et al | PROSPERO
|
|
|
10/28/20
|
Caldeira D, Prada L, Baiao R, et al | PROSPERO
|
|
|
10/27/20
|
Aridas A, Sheen J, Reupert A, et al | PROSPERO
|
|
|
10/27/20
|
Bhatnagar S, Rijhwani K, Dhokar A | PROSPERO
|
|
|
10/27/20
|
Jiao LR, An XX, Lu CX, et al | PROSPERO
|
|
|
10/27/20
|
Shi J, Li Y, Zhao L, et al. | Research Square
Aim: To provide comprehensive and continuously updated data to explore the prevalence of depression, anxiety, delirium, and post-traumatic stress disorder (PTSD) among COVID-19 patients.
|
|
|
10/27/20
|
Patanavanich R, Glantz SA | medRxiv
Aim: To compare the association between smoking and COVID-19 disease progression between unadjusted analyses with adjusted analyses to examine whether smoking is an independent risk factor.
CLINICAL CHARACTERISTICS
|
|
|
10/27/20
|
Mondal R, Deb S, Shome G, et al. | medRxiv
Aim: To summarise so far available pieces of evidence documenting SARS-CoV-2 mediated spinal demyelination in terms of clinical, laboratory parameters and imaging characteristics.
CLINICAL CHARACTERISTICS
|
|
|
10/27/20
|
Feizullayeva C, Katz J, Vialet J, et al | PROSPERO
|
|
|
10/27/20
|
Lee M, Kim S, Shin J, et al | PROSPERO
|
|
|
10/27/20
|
Lumngwena EN, Njoku KF, Ndibangwa P, et al | PROSPERO
|
|
|
10/27/20
|
Li F, Lu H, Li X, et al. | Medicine
Aim: To ascertain the association between COVID-19 and intestinal flora that will facilitate management or prevention strategies of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/26/20
|
Tandon M, Mehta TR, Daimee M, et al. | Research Square
Aim: To establish a pattern and understand the significance of CSF analysis which can possibly be useful in deciding prognosis and exploring therapeutic options in the future.
|
|
|
10/26/20
|
Patrick K, Pothamsetty N, Tello LY | PROSPERO
|
|
|
10/26/20
|
Zhang R, Gao Y, Xie D, et al. | Research Square
Aim: To analyze research collaboration, interventions, and outcome measures in registered SRs of treatment associated with COVID-19 and point out the problem.
|
|
|
10/26/20
|
Williams V, Dash N, Suthar R, et al | medRxiv
Aim: To synthesize the current data on clinico-laboratory features, intensive care needs, treatment, and outcome of Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) or multisystem inflammatory syndrome in children (MIS-C). UPDATED
|
|
|
10/26/20
|
Maciel A, Xavier M, Neto JR, et al | PROSPERO
|
|
|
10/26/20
|
Treskova M, Haas L, Scholz S, et al | PROSPERO
|
|
|
10/26/20
|
Yarandi RB, Panahi MH, Hatami H, et al | PROSPERO
|
|
|
10/26/20
|
Richards GC, Khaira TS, Aronson JK, et al | PROSPERO
|
|
|
10/26/20
|
Yin S | PROSPERO
|
|
|
10/26/20
|
Regmi K, Lwin C | BMJ Open
|
|
|
10/26/20
|
Parsons N, Outsikas A, Parish A, et al. | medRxiv
Aim: To quantify the locations of small neurological events identified with magnetic resonance imaging (MRI) among COVID-19 patients. UPDATED
|
|
|
10/26/20
|
Kloppenburg J, Singh S, Leftwich H, et al | PROSPERO
|
|
|
10/26/20
|
Wu Q, Jiang Y, Zhang M, et al | PROSPERO
|
|
|
10/26/20
|
Balakumar S | National Collaborating Centre for Infectious Diseases
|
|
|
10/26/20
|
Alkofide H, AlOtaibi B, AlMuhaini S, et al | PROSPERO
|
|
|
10/26/20
|
Benefield AE, Skrip LA, Clement A, et al. | medRxiv
Aim: To provide pooled time-series distributions of coronavirus viral load and the duration of viral shedding across patient subgroups defined by demographic and clinical characteristics, after controlling for study-specific methodologies.
CLINICAL CHARACTERISTICS
|
|
|
10/26/20
|
Balakumar S | National Collaborating Centre for Infectious Diseases
|
|
|
10/26/20
|
Galway R, Swales M, Wane J | PROSPERO
|
|
|
10/23/20
|
Byambasuren O, Dobler CC, Bell K, et al. | medRxiv
Aim: To estimate the range of valid seroprevalence rates of SARS-CoV-2 in different populations, and compare these seroprevalence estimates with the cumulative cases seen in the same population.
|
|
|
10/23/20
|
dos Santos Cunha CRS, Belo Fort MPM, Teixeira Pereira PTV | PROSPERO
|
|
|
10/23/20
|
Hurst J, Porter J, Althobiani M | PROSPERO
|
|
|
10/23/20
|
Amimo F, Lambert B, Magit A, et al. | PROSPERO
|
|
|
10/23/20
|
Riera R, Bagattini A, Pachito D, et al. | PROSPERO
|
|
|
10/23/20
|
Elsawah H, Elsokary M, Elshafie A, et al. | PROSPERO
|
|
|
10/23/20
|
Ghosn L, Davidson M, Boutron I | PROSPERO
|
|
|
10/23/20
|
Chan J, Reed A, Lim N, et al. | PROSPERO
|
|
|
10/23/20
|
Franceschi Jr VB, Santos Jr AS, Glaeser JR AB, et al. | medRxiv
Aim: To evaluate the qualitative aspects of population-based seroprevalence surveys of COVID-19, including their reliability and biases. UPDATED
|
|
|
10/23/20
|
Berhane M, Abate S | PROSPERO
|
|
|
10/23/20
|
Cares K, Montenegro Y, Torres R, et al. | PROSPERO
|
|
|
10/23/20
|
Hajikhani B, Nasiri J, Dadashi M | PROSPERO
|
|
|
10/23/20
|
Dobbins M | National Collaborating Centre for Methods and Tools
|
|
|
10/23/20
|
Sehgal A, Orenstein S, Tang K | PROSPERO
|
|
|
10/23/20
|
Yan C, Sun C, Chen C, et al. | PROSPERO
|
|
|
10/22/20
|
Li Y, Liang Y, Xu M | PROSPERO
|
|
|
10/22/20
|
Adil M, Gaba U, Azharuddin M, et al. | PROSPERO
|
|
|
10/22/20
|
Omodan A, Olojede S, Lawal S, et al. | PROSPERO
|
|
|
10/22/20
|
James P, Ali Z, Armitage A, et al | medRxiv
Aim: To provide a systematic review of the latest evidence on how malnutrition across all its forms (under- and over-nutrition and micronutrient status) may influence both susceptibility to, and progression and severity of, COVID-19. UPDATED
|
|
|
10/22/20
|
Am X, Weng X, Huang Q | PROSPERO
|
|
|
10/22/20
|
Wang Q, Liu J, Shao R, et al. | PROSPERO
|
|
|
10/22/20
|
Golinelli D, Boetto E, Carullo G, | J Med Internet Res
Aim: To describe which digital solutions have been reported in the early scientific literature to mitigate the impact of COVID-19 on individuals and health systems.
|
|
|
10/22/20
|
da Silva Melo Malaquias T, do Campos Fernandez Lourenco Haddad M, Okubo CVC, et al. | PROSPERO
|
|
|
10/22/20
|
Diaz LA, Lagos A, Aliaga R, Garcia-Huidobro F, et al. | PROSPERO
|
|
|
10/22/20
|
Murthy S, Sterne J, Tritscheler T, et al. | PROSPERO
|
|
|
10/22/20
|